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This review discusses the potential usefulness of the worm Caenorhabditis elegans as a model organism 
for chemists interested in studying living systems.  C. elegans, a 1-mm long roundworm, is a popular 
model organism in almost all areas of modern biology.  The worm has several features that make it 
attractive for biology: it is small (<1000 cells), transparent, and genetically tractable.  Among 
multicellular organisms, C. elegans is arguably one of the simplest and easiest to work with.  Despite its 
simplicity, the worm exhibits complex phenotypes associated with multicellularity: the worm has 
differentiated cells and organs, it ages and has a well-defined lifespan, and it is capable of learning and 
remembering.  This review argues that the balance between simplicity and complexity in the worm will 
make it a useful tool in determining the relationship between molecular-scale phenomena and 
organism-level phenomena, such as aging, behavior, cognition, and disease.  Following an introduction 
to worm biology, and a comparison of worm biology with human biology, the review provides examples 
of current research with C. elegans that is either chemically relevant or potentially interesting to those 
with a molecular focus.  It also describes tools—biological, chemical, and physical—that are available to 
researchers studying the worm. 
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1  Introduction 
Chemistry underlies biology: molecular interactions provide the foundation and structure 
of all life.  Chemists, however, are not biologists.  What, then, should be the subject, and goal, of 
a chemist who is studying living systems?  One response to this question is that chemists should 
work to understand the nature of biomolecules and the interactions among them.  For example, 
molecular phenomena such as molecular recognition, the hydrophobic effect, multivalency, 
enzymatic catalysis, and signal transduction are far from fully understood and remain active and 
important topics of research.  At its most reductionist level, this type of research focuses on 
processes involving individual molecules, small numbers of molecules, individual reactions, and 
small networks of reactions. 4 
 
Pursuing an understanding of biology at the level of molecules is clearly an important 
goal, and one for which chemistry is uniquely suited.  But what of higher-level questions?  What 
is life?  How do networks of molecules, molecular interactions, and reactions—properly 
compartmentalized—develop and maintain the astonishing set of characteristics we attribute to 
“life”?  Molecules are not alive, but organized networks of the reactions that interconvert them 
are; how does this transformation occur?  These questions cannot be answered using only 
molecules—there are limits to reductionism—one must look to cells and organisms.  Further, 
there are questions that may only be answered using multicellular organisms.  What is aging?  
What is disease?  What is cognition?  What is behavior?  How do fundamental molecular 
interactions aggregate into these complex phenomena?  How are organisms organized from cells, 
and how do the component cells interact and communicate?  How does a fertilized egg—a single 
cell—differentiate into an organism?  This second set of questions highlights an opportunity for 
chemists to explore how the biochemical processes that go on within, and between, individual 
cells relate to the complex phenotypes of multicellular organisms, including humans. 
1.1  Choosing Models: What is the Best Organism for Chemists? 
Evolution has resulted in a great variety of living creatures, ranging from the simplest 
bacterium to the most complex, large, multicellular organisms.  “Complexity” can mean many 
things;
[1, 2] by “complex organism,” we mean one with a large number of parts, and a large 
number of interactions between those parts.
[3, 4]  We also use complexity to refer to 
organizational complexity: all organisms have cells, but in more complex organisms, those cells 
may be organized into tissues, and, beyond tissues, into distinct organs.
[3, 4]  The variety and 
diversity of life is so enormous that—to focus efforts, and avoid intellectual pointillism—it is 5 
 
necessary to concentrate investigation on a small number of organisms, chosen for experimental 
convenience, and try to understand those organisms in detail.  The organisms chosen for this type 
of study are called “model” organisms.  Table 1 compares a selection of model organisms from 
both a scientific standpoint, and from the practical consideration of their tractability for study by 
chemists. 
The simplest model organisms are unicellular: single-celled bacteria, algae, yeasts, and 
protozoa.  Unicellular organisms are, of course, alive, and are the best organisms with which to 
address many of the issues surrounding the question “what is life?”  E. coli is certainly the most 
studied; Mycoplasma genitalium, with the smallest genome of any known organism that can 
reproduce independently in pure culture,
[5] is perhaps the best suited for understanding the core 
question of how molecular networks become alive.  Unicellular organisms are very convenient to 
study in some regards, but also have disadvantages.  Although the simplicity of these organisms 
(in regards to the degree of intercellular interaction, amount of differentiation, and size and 
complexity of the genome) can be beneficial in experiments, their usefulness in addressing 
higher-order biological questions is limited.  Yeast and bacterial cells may exhibit changes over 
time that are suggestive of cellular aging
[6, 7] (for example, mother cells of the budding yeast 
Saccharomyces cerevisiae can produce only a limited number of daughter cells
[6]), but aging in 
these cells lacks the great diversity of phenotypes involved in mammalian aging. 
The higher-order phenomena that are most relevant to humans—phenomena like aging, 
disease, cognition—appear in complex form in multicellular life only.  What is the best organism 
for chemists to use in studying complex, multicellular organisms, and more generally 
multicellularity, and its consequences, in life?  The ideal organism would be complex enough to 6 
 
address higher-order questions, but simple enough to be experimentally tractable and easy to 
work with.  Multicellular organisms include i) organisms that exhibit little or no cellular 
differentiation and do not have a well-defined lifespan (such as filamentous yeasts and bacteria), 
ii) organisms that exhibit more cellular differentiation than the first group, but do not have 
cellular types or body structures that are analogous to those in humans, and do not have a well-
defined lifespan (such as multicellular fungi, multicellular algae, social amoebae, and plants), 
and iii) organisms that do have differentiated tissues and distinct organs, and have a defined 
lifespan.  It is in the third group—which includes worms, flies, zebrafish, mice, primates, and 
humans—that organisms exhibit the level of biological complexity in which we, as humans, are 
most interested.  The organisms in this group that have the most relevance to human biology—
other mammals, such as mice and primates—are also the most difficult to work with, because of 
complexity and expense.  One of the simplest organisms in this group is the nematode 
Caenorhabditis elegans: a 1-mm long roundworm that has an average lifespan between two and 
three weeks at 20 °C, and is easy and inexpensive to cultivate. 
Experimentally, the culture of C. elegans is far simpler than the maintenance of higher 
organisms, such as mice, and is also far simpler than the culture of mammalian cells.  
Experiments with C. elegans are free of the ethical concerns—and accompanying regulations—
associated with working with higher organisms, particularly vertebrates.  The maintenance of 
C. elegans requires no specialized training or equipment.
[8]  Worms can grow at room 
temperature, and in unmodified air; it is thus possible to maintain cultures on the laboratory 
bench.  Requirements of sterility are less stringent with C. elegans than with cultures of 
mammalian cells because contaminated stocks of C. elegans are easily identified and cleaned.
[8]  7 
 
In addition, when multiple strains of C. elegans are maintained simultaneously, the occurrence of 
unrecognized cross-contamination—a significant concern in the use of mammalian cell lines
[9]—
is unlikely.  Thus worms provide chemists with a tractable platform for quickly testing chemical 
hypotheses in a simple multicellular organism. 
In this review, we will argue that C. elegans is an organism of just the right level of 
complexity to enable chemists to pursue a molecular understanding of multicellular life (and thus 
of metabolism, regulation of networks, many features of biological information storage, 
transmission, and expression, development, reproduction, aging, disease, and death).  This 
complexity is balanced with an ease-of-use, which should enable C. elegans to be easily adopted 
by chemical research groups—an important consideration for chemists who wish to keep a 
molecular focus, and who do not wish to embrace the technical rigors of mammalian cell culture, 
or the expense, complexity, and regulatory difficulties of working with mammals.  The ease with 
which the worm can be adopted should encourage chemists to study not only the worm, but 
organisms in general.  For chemists and other scientists who are interested in molecular 
organismic biology, but do not have experience working with model organisms, the worm is a 
useful starting point. 
1.2  Sydney Brenner and the Selection of C. elegans as a Model Organism 
In the early 1960s, Sydney Brenner, then at the MRC Laboratory of Molecular Biology at 
Cambridge, selected, developed, and popularized the use of C. elegans (or, simply, “the worm”) 
for biological research, particularly as a model for development and organogenesis; for this work 
he received the Nobel Prize in Physiology or Medicine in 2002.
[10]  Since its popularization by 
Brenner, the worm has become a widely-used model organism in biology.   8 
 
Following the discoveries of the structure of DNA, and the processes of translation and 
transcription in the middle part of the 20
th century, there was a feeling in the group that included 
Brenner and his colleagues that molecular biologists had solved, or were well on their way to 
elucidating the details of, the problems of classical molecular biology—principally, the nature of 
the replication and expression of DNA.  The field had accomplished this work largely using 
bacteria and bacteriophage, which were useful model organisms because of their simplicity and 
the fact it was possible to manipulate them in large numbers easily.
[11]  Whether right or wrong in 
his assessment of his field, Brenner was interested in shifting the focus of molecular biology 
from the chemical details of biomolecular machinery to higher-level biological processes, 
particularly development, and also neuronal function.
[11]  For such processes, bacteria and phages 
were no longer appropriate models; this consideration inspired Brenner to seek out a higher 
organism—one that could be manipulated like a microorganism, and could be studied using the 
tools of molecular biology.    
Brenner wanted an organism that had a short generation time, to simplify the study of 
development, and a relatively small number of cells, to enable the tracking of cellular 
lineages.
[11]  He also wanted an organism that was straightforward to cultivate, and was easily 
observed with a microscope.
[11, 12]  For the study of development, Brenner initially considered 
unicellular organisms that exhibit some form of cellular differentiation—including the bacterium 
Caulobacter, and the protist Naegleria (Table 1)—but concluded that these organisms were 
biological curiosities, and thus too exotic to be useful as model organisms.
[12]  He also 
considered rotifers—which are multicellular, and have differentiated tissues and organs 9 
 
(Table 1)—but was frustrated by their slow reproduction and complex life cycles.
[12]  
Eventually, Brenner settled on C. elegans as the simplest organism that met his criteria.   
C. elegans has a short generation time (a fertilized eggs develops into a sexually mature 
adult in approximately 3 days at 20 °C) and a short lifespan (the average lifespan is between two 
and three weeks at 20 °C) and can be cultivated in the laboratory on a diet of bacteria (typically 
E. coli), either on agar plates or in liquid.  Figure 1a shows a photomicrograph of worms 
crawling on the surface of an agar plate.  The worm is small in size (the adult is 1 mm in length, 
and 50 µm in width), and has a small number of cells (adult hermaphrodites have 959 somatic 
cells; adult males have 1031).  Figure 1b displays an image of an adult hermaphrodite.  The 
transparency of the body of the worm enables every nucleus in the worm to be imaged using 
light microscopy.   
The worm has two sexes: self-fertilizing hermaphrodites, and males, which arise rarely 
(0.1% of the time) from self-fertilization.  This division of the sexes was an attractive feature to 
Brenner from the standpoint of genetic analysis, as males could be crossed with hermaphrodites 
to produce new combinations of mutant genes.  In the past 50 years, further developments in 
research have made C. elegans even more attractive as a model organism; these developments 
include i) the reconstruction of the complete lineage of every cell in the worm from fertilization 
to maturity by John Sulston and colleagues,
[13, 14] ii) the reconstruction of the entire nervous 
system of C. elegans by John White and colleagues,
[15] iii) the discovery of the usefulness of 
RNA interference in manipulating the expression of genes in C. elegans by Andrew Fire and 
Craig Mello,
[16] and iv) the publication of the complete genetic sequence of the worm by the 
C. elegans Sequencing Consortium.
[17, 18] 10 
 
Brenner’s goal—to find a simple model organism with which to correlate genetic 
manipulations and developmental effects—is a specific instance of the goal we propose for 
chemists—to find an organism with which to correlate generic chemical states (pH, level of 
oxidation, net charge) or processes (protein-ligand interactions, redox reactions) to phenomena at 
the level of the organism.  Brenner sought to find the simplest possible organism that allowed the 
correlation to be made.  The success of the worm as a model organism for studying the genetics 
of complex phenomena in biology confirms Brenner’s insight in selecting C. elegans.   
Although a large amount of work has examined the organismic consequences of genetic 
modifications, there has been relatively little work done to explore the organismic consequences 
of chemical modifications.  Many of the features that make the worm so valuable to molecular 
biologists and geneticists will also make the worm useful to chemists.  The handoff of worms 
from biologists to chemists is a natural step in the reductionist cascade in science. 
1.3  Scope of Review 
In this review, we first present a brief overview of the biology of C. elegans and discuss 
the relevance of the worm as a model organism for organismic (and some aspects of human) 
biology.  We then present examples from the literature illustrating how C. elegans can be used to 
link chemical details to phenomena at the organismic level.  Although the principal focus of the 
review is the fundamental biochemistry of the worm, we also sketch its relevance to human 
disease.  A number of important human diseases (largely in the developing world) are due to 
nematodes or parasitic worms of similar complexity, and the study of C. elegans is directly 
relevant to these diseases.  To provide chemists with a starting point for research, we review the 
biochemical, chemical, and physical tools that are available to facilitate research with the worm.  11 
 
We conclude by considering the opportunities that lie ahead for chemists in the field of worm 
biology.  We discuss opportunities both for tool makers—those who develop devices and 
protocols useful in studying the molecular biochemistry of the worm—and tool users—those 
who can use these tools to study the biochemistry. 
2  Worm Biology 
Gaining a complete understanding of fundamental biological processes is a goal at the 
very core of science.  The simplicity of the worm makes it an excellent starting point in this 
pursuit.  From an applied perspective, it is also interesting to consider the relationship between 
worm biology and human biology.  How useful is knowledge gained with the worm for 
understanding human biology, health, and disease?  This section provides an overview of worm 
biology, and, where relevant, compares human and worm biology.  Table 2 lists some online 
resources for learning more about C. elegans biology.  A review by Antoshechkin and Sternberg 
provides a detailed description of online databases and tools that facilitate the study of 
C. elegans.
[19] 
2.1  Development and Lifespan 
C. elegans begins life as an embryo, and progresses through four larval stages—termed 
L1, L2, L3, and L4—before becoming a fully-developed, sexually mature adult.  At 20 °C, the 
generation time—the time between fertilization and the onset of reproduction in adulthood—is 
approximately 2-3 days, and the average lifespan is between two and three weeks.
[20]  During the 
transition from L1 to L2, if C. elegans experiences low concentrations of food or crowding (high 
population density), it may also form an alternative third larval stage known as dauer—which is 12 
 
a German word meaning “enduring”.  Dauers are motile, but do not feed, and develop a thick 
cuticle that protects them from treatment with harsh chemicals, such as sodium dodecyl sulfate 
(SDS).
[21]  When levels of food increase, or population density decreases, dauer larvae can 
proceed to the L4 larval stage.
[20]  As dauers, C. elegans can live for several months.
[22]  
In the laboratory, the typical source of food for C. elegans is a slow-growing strain of 
E. coli, OP50.
[23]  While the use of E. coli as a food source was likely a convenient choice when 
Brenner was developing the worm as a model organism, E. coli is probably not the principal food 
source for C. elegans in nature.  In fact, there is evidence that suggests E. coli may even be 
pathogenic to C. elegans.
[24, 25]  Researchers have isolated wild C. elegans from garden soil and 
compost, and also from snails, woodlice, and other invertebrates.
[26]  The diet of C. elegans in 
these environments is not known, but may include microorganisms associated with rotting 
organic matter.  Studies in C. elegans and other Caenorhabditis species suggest that the 
association between C. elegans and macroscopic invertebrates like snails and woodlice facilitates 
the dispersal of worms.
[26]  This association may also be necromenic—that is, worms may feed 
on the corpse of the host after it dies.
[26]  It is possible to grow C. elegans using bacteria-free, 
chemically-defined media; for unknown reasons, however, worms develop more slowly in 
bacteria-free medium than they do when fed bacteria.
[27]  We discuss this issue in more detail in 
Section 3.2.2. 
2.2  The Genome and Proteome 
Despite the simplicity of the worm, there is substantial overlap between worm and human 
with respect to genes and biochemical pathways.  Although the genome of the worm is 
substantially smaller than that of humans (the C. elegans genome is ~100 Mb; the H. sapiens 13 
 
genome is ~3,000 Mb), the worm has nearly as many genes (worms have ~20,000 genes; humans 
have ~23,000).
[18]  Bioinformatic analyses suggest that 60-80% of the genes of the worm are 
homologous to human genes.
[28]  (Homologous genes are genes in different organisms that 
evolved from a common ancestor; it is possible to identify putative homologs on the basis of 
sequence similarity in the genetic code .
[29]) 
To diversify its proteome, C. elegans can perform both post-transcriptional modifications 
(alternative splicing of messenger RNA) and post-translational modifications (covalent 
modification of proteins).  Alternative splicing of genes occurs to a much greater extent in 
humans than in worms: at least 60% of human genes have at least one alternative form; in the 
worm, only approximately 10% of genes have alternative forms.
[30]  Thus the proteome of 
H. sapiens is probably significantly larger, and more complex, than that of C. elegans.  The 
C. elegans genome encodes proteins that enable a repertoire of post-translational modifications 
that is similar to that of humans; these modifications include phosphorylation, acylation 
(including acetylation of histones), ubiquitination,
[31] alkylation (including methylation, and 
prenylation
[32]),  and glycosylation (including N- and O-linked).
[33] 
2.2.1  The Organization of Genes in C. elegans 
Unlike other eukaryotes, worms use operons—genetic structures in which a single 
upstream promoter regulates the serial transcription of a group of genes into a single strand of 
messenger RNA—to regulate the co-expression of genes.  (In other eukaryotes, each gene 
typically has its own promoter region.
[34])  Approximately 15% of protein coding genes in 
C. elegans are found in operons.
[35]  Prokaryotes also use operons (e.g., the lac operon of E. coli), 
but operons in nematodes most likely evolved independently, possibly because the short time 14 
 
between mitotic divisions in embryogenesis created a selective pressure towards a smaller 
genome.
[36]  The use of operons is a partial explanation for the C. elegans genome being 
approximately 30 times smaller than the human genome, despite having a similar number of 
genes.  A second explanation is that the C. elegans genome contains less non-coding DNA 
(i.e., DNA that does not code for proteins).  For example, transposable elements—mobile 
segments of DNA that do not code for proteins—and their inactive (immobile) remnants account 
for approximately 12% of the C. elegans genome, but nearly 50% of the human genome.
[37]  
Overall, coding DNA makes up 25.55% of the C. elegans genome, but only 1.5% of the human 
genome.
[36]  
2.3  Pathways of Signal Transduction 
Many of the biochemical pathways associated with signal transduction are at least 
partially conserved between humans and worms.
[38]  Reference [38] includes a comparison of 
signal transduction pathways in worms and humans.  Some pathways show a high degree of 
conservation.  For example, the genome of C. elegans has homologs for all of the components of 
the transforming growth factor β (TGF-β) pathway.
[39]  In contrast, some other human pathways 
are only partially present in C. elegans (the Toll-like receptor pathway and the JAK/STAT 
signaling pathway,
[40] for example), and still others are believed to be absent in C. elegans 
(e.g., the hedgehog signaling pathway).
[38, 39]  One of the best studied signaling pathways in 
C. elegans is the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway.
[41]  This 
pathway contains a single insulin/IGF-1 receptor, DAF-2, the inactivation of which results in an 
increased lifespan in C. elegans.
[42]  The C. elegans genome contains 37 insulin-like proteins; 
INS-1 is the most closely related to human insulin.  Both INS-1 and human insulin are DAF-2 15 
 
antagonists.  Many of the members of the insulin/IGF-1 signaling pathway are conserved among 
worms, flies, and mammals.  Mutation of the daf-2 equivalent in Drosophila also increases 
lifespan, thus raising the intriguing possibility that molecular mechanisms for controlling 
lifespan are conserved across species.
[43] 
A type of signaling in C. elegans that is not well understood is the use of hormones for 
nuclear signaling.
[44]  The genome of the worm encodes 284 genes that, based on sequence, are 
predicted to be nuclear hormone receptors.
[45]  In contrast, the human genome has 48 predicted 
nuclear hormone receptors.
[46]  Approximately 15 of the predicted nuclear hormone receptors in 
C. elegans are believed to be homologous to nuclear hormone receptors in humans.
[47]  The 
identity of the corresponding ligand is unknown for all but one of the predicted receptors in 
C. elegans; researchers recently identified three cholesterol-derived molecules that serve as 
ligands for the nuclear receptor DAF-12, which influences development (dauer formation) and 
reproduction in C. elegans.
[48]  For some nuclear receptors, it is possible to predict the identity of 
the corresponding ligand based on motifs in the sequence of the gene that correspond to known 
recognition sites in other organisms; for example, based on sequence data, the corresponding 
ligand for the C. elegans nuclear hormone receptor NHR-14 is most likely an estrogen or 
estrogen-like compound.
[49]   
2.4  Basic Anatomy and Physiology 
Despite the simplicity of the anatomy of the worm, many tissues and organs in C. elegans 
have structures and/or functions that are recognizably similar to our own: muscle tissue in 
C. elegans looks like human muscle; neurons in C. elegans look like human neurons (although 
they are not myelinated and do not have Schwann cells; they do, however, have glial cells that 16 
 
support neuronal function and structure
[50]); the pharynx, gut, and uterus of the worm have clear 
analogs in human anatomy.   
2.4.1  Organs and Tissues 
The anatomy of C. elegans includes an alimentary system (mouth, pharynx, intestine, 
rectum, anus), a reproductive system (gonad, uterus, spermatheca, vulva in the hermaphrodite; 
gonad, seminal vesicle, vas deferens, cloaca in the male), a nervous system (302 neurons in the 
hermaphrodite, with a cluster of synapses—the “nerve ring”—located in the head), and an 
excretory system (a group of four cells believed to control osmolarity and the elimination of 
waste).
[20]  Worms have muscle (striated and non-striated), hypodermis, a protective cuticle 
covering the body (secreted by the hypodermis), as well as connective tissues and basement 
membrane.
[20]  The cuticle is a 0.5-µm thick coating on the external surface of the worm; it 
comprises five layers (from innermost to outermost): a layer of collagen fibrils, a fluid-filled 
layer with “struts” of collagen, a layer of collagens and cuticle-specific proteins, a layer of lipids, 
and a surface coat of glycoproteins.
[20]   
The body of the worm is essentially a tube—the alimentary tract—inside of another 
tube—the hypodermis and cuticle.  Between the two tubes is a fluid-filled body cavity—the 
pseudocoelom.
[20]  C. elegans does not have a circulatory system, and relies on passive diffusion 
in the pseudocoelomic fluid for the transport of O2, CO2, and nutrients.  It is also possible that 
the locomotory movement of the body of the worm mixes the contents of its interior fluid.  Gas 
exchange with the environment occurs by diffusion through the cuticle or the surface of the 
gut.
[51] 17 
 
2.4.2  Immune System of the Worm Is Not Adaptive 
Unlike humans and other vertebrates, C. elegans does not have an adaptive immune 
system; C. elegans does not produce antibodies.  Instead, the worm relies on innate recognition 
and responses to protect itself from pathogens.
[52]  Although the innate immunity of the worm is 
not entirely characterized, it is known that some signaling pathways used in innate immunity are 
conserved in C. elegans and humans, including the p38 mitogen-activated protein kinase 
pathway, and the apoptotic pathway.
[52]  In addition, pathways known to play a role in adaptive 
immunity in mammals appear to be involved in the innate immunity of C. elegans: the TGF-β 
pathway controls T cell differentiation in mammals, and is involved in the induction of the innate 
immune response in C. elegans.
[52] 
The response of the worm to pathogenic bacteria involves the use of lysozymes, which 
attack bacterial cell walls, and caenopores, which are peptides that disrupt bacterial cell 
membranes, to break up bacteria.  The immune response of the worm also involves up-regulation 
of the expression of catalases, superoxide dismutases, metallothioneins, and glutathione 
S-transferases—molecules that are likely involved in detoxification.
[52]  In addition, the body 
cavity of the worm contains six coelomocytes—six large (10-15 µm wide) cells believed to play 
a role in the immune system of the worm by taking up foreign or toxic molecules via 
endocytosis.
[52] 
2.4.3  Neurobiology 
In C. elegans, adult hermaphrodites have 302 neurons.  Unlike neurons in vertebrates, 
neurons in C. elegans are not myelinated.  Only a subset of neurons in C. elegans appear to 18 
 
generate classical “all-or-nothing” action potentials.
[53] Rather than action potentials, most 
neurons in the worm exhibit graded potentials, the shapes of which depend on the amplitude, 
duration, and shape of the signal that stimulated neuronal activity.
[54]  Despite these differences, 
worms use many of the same neurotransmitters as humans, and the mechanisms for the 
biosynthesis, release, recognition, and removal of neurotransmitters are highly conserved in 
worms and humans.
[55]  Table 3 compares neurotransmitters used in worms and humans.  
C. elegans neurons are also responsive to many compounds that are neuroactive in humans, 
including acetylcholinesterase inhibitors,
[56] serotonin-specific reuptake inhibitors,
[57] and 
anesthetics.
[58]  
C. elegans exhibits a variety of behaviors—including locomotion (crawling and 
swimming), feeding (pharyngeal pumping), defecation, egg-laying, and mating (when the 
population contains males)—that are easy to observe.
[59]  Laser ablation of neurons has enabled 
the elucidation of the neuronal circuits involved in each of these behaviors.
[59]  C. elegans can 
sense, and respond to, chemical, mechanical, and thermal stimuli in surprisingly sophisticated 
ways for an organism with only 302 neurons.  Worms are capable of multiple forms of 
learning—defined as a change in behavior based on experience—including habituation and 
classical conditioning.
[60]  Worms also have memory.  For example, when provided with food at 
a specific temperature and then transferred to a thermal gradient, worms locate, and crawl along, 
the isotherm corresponding to the original feeding temperature.
[61] 
2.5  Metabolism and Energy 
The presence of sequences in the genome of the worm that correspond to functional 
motifs in human proteins suggests that pathways associated with the breakdown of nutrients, the 19 
 
storage of energy, and the synthesis of small molecules are highly conserved between worms and 
humans.
[62]  For some, but not all, potentially-conserved genes, experiments have confirmed that 
the associated protein is expressed and functional.
[63]  The genome of the worm contains genes 
coding for all of the proteins necessary for the fundamental pathways of cellular respiration: 
glycolysis (the conversion of glucose to pyruvate), pyruvate decarboxylation (formation of 
acetyl-coA from pyruvate), β-oxidation of fatty acids, the citric acid cycle, the electron transport 
chain, and ATP synthesis.
[63]  Like mammals, C. elegans uses flavin adenine dinucleotide (FAD) 
and nicotinamide adenine dinucleotide (NAD
+) as cofactors in cellular respiration.  The proteins 
involved in these pathways are highly conserved between humans and worms.
[62-64]   
To meet energetic needs under anaerobic conditions, C. elegans—like humans—can rely 
on anaerobic glycolysis, which produces lactic acid as a waste product.  Unlike humans, 
however, cells in C. elegans can also perform ethanolic fermentation
[63] and malate 
dismutation—a metabolic pathway, also found in parasitic nematodes, that employs a specialized 
mitochondrial electron transport chain.  This chain uses fumarate, rather than oxygen, as the 
electron acceptor, and produces acetate, succinate, and propionate as waste products, rather than 
carbon dioxide and water.
[65] 
Worms can generate glycogen from glucose for the storage of energy.  Glycogen makes 
up approximately 3.3% of the dry mass of adult worms.
[66]  The principal location of glycogen 
storage in worms is in the gut.
[33]  In mammals, enzymes can break down stored glycogen in the 
liver into glucose, which can circulate in the bloodstream to meet the energetic demands of 
tissues throughout the body.  C. elegans lacks glucose-6-phosphatase, which is required for the 
final step in the breakdown of glycogen into glucose.
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glucose from glycogen using trehalose as an intermediate; worms have enzymes that catalyze the 
synthesis of trehalose from glucose-6-phosphate, as well as enzymes that catalyze the hydrolysis 
of trehalose into glucose.
[64]  It is unknown whether it is trehalose, glucose, or both that diffuse 
from glycogen stores to energy-requiring tissues following the breakdown of glycogen.
[62, 64] 
Worms also store energy as lipids.  Triacylglycerides and free fatty acids make up 
approximately 36% of the dry mass of adult worms.
[66]  C. elegans can obtain fatty acids from 
dietary sources (from the bacteria they eat), or from de novo biosynthesis.  Like humans, 
C. elegans synthesizes, and uses, saturated, monounsaturated, polyunsaturated, and branched 
chain fatty acids.
[67, 68]  In C. elegans, fat stores are located in the hypodermis and in droplets in 
intestinal cells.
[69]   
C. elegans cannot synthesize sterols de novo.  The worm has genes coding for the 
necessary molecular machinery for the synthesis of the polyisoprenoid molecule farnesyl 
pyrophosphate, a precursor of dolichols, ubiquinone, and sterols.  The steps in this synthetic 
pathway are conserved in humans and worms.  While the worm can proceed to synthesize 
dolichols and ubiquinone, it cannot produce sterols from farnesyl pyrophosphate.  The worm 
therefore requires a dietary source of fully-synthesized sterols—or their immediate synthetic 
precursors—from plants or animals.
[70]  In the laboratory, media for C. elegans typically contains 
cholesterol.
[8]   Interestingly, because statins, a class of drugs that lower levels of cholesterol in 
humans, lower cholesterol by inhibiting the activity of 3-hydroxy-3-methylglutaryl-CoA 
(HMG-CoA) reductase, which acts upstream of farnesyl pyrophosphate in the biosynthesis of 
sterols, the worm may be a particularly useful model for investigating effects of statins that are 
independent from the reduction in levels of cholesterol.
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Worms require a dietary source of heme, and—in contrast to mammals, yeast, and 
bacteria—appear to lack several enzymes required for the biosynthesis of heme.
[71]  Analysis of 
the genome of C. elegans suggests that worms generate a number of heme-containing proteins, 
including globins, guanylate cyclases, adenylate cyclases, catalases, cytochrome P450s, and 
cytochromes involved in cellular respiration.
[71]  Bacteria provide a source of heme when 
C. elegans is grown using bacteria as a food source.  It is also possible to supply worms with 
heme by adding hemin chloride or heme-containing proteins, such as hemoglobin, myoglobin or 
cytochrome c, to the media.
[62, 71]  Worms also require dietary sources of specific amino acids.  
Table 3 compares essential and non-essential amino acids in humans and worms.   
2.5.1  C. elegans Can Survive Hypoxia and Anoxia 
Interestingly, worms are able to survive periods of anoxia (no oxygen) and hypoxia (low 
oxygen).  At oxygen tensions down to ~3.6 kPa (0.036 atm), the metabolic rate of C. elegans—
as measured by monitoring carbon dioxide production
[72] or oxygen consumption
[73]—remains 
indistinguishable from that of worms in normoxic environments, where the oxygen tension—or 
partial pressure—is  .  Below the threshold of 3.6 kPa, metabolic rate decreases with 
decreasing oxygen tension.  At an oxygen tension of 1 kPa, the metabolic rate of C. elegans is 
half of that of worms in normoxic conditions.
[72, 73]  C. elegans can survive limited exposure to 
anoxic conditions (defined in one study as  <0.001 kPa
[74]).  All developmental stages of 
worms, from embryos to adults, exhibit relatively high rates of survival (~85-90%) following 
exposure to anoxia for 24 h.
[74-76]  The survival of worms to anoxia declines with longer 
exposure: after 72 h of anoxia, the rate of survival decreases dramatically for adult worms to 22 
 
~5-10%.
[75, 76]  Larvae (L1-L4 stage worms) show a similar decline in survival after 72 h of 
exposure.
[76] 
How do worms survive anoxia?  Exposure to anoxia causes worms to enter a state of 
suspended animation, characterized by an absence of locomotion, feeding, egg-laying (in adults), 
and development (in embryos and larvae).
[75, 77]  This arrested state may minimize energetic 
needs and promote survival during anoxia.  In addition, anoxic exposure results in the production 
and excretion of L-lactate, acetate, succinate, and propionate by C. elegans.
[78]  The production 
of these metabolites suggests C. elegans uses anaerobic metabolic pathways—lactic acid 
fermentation and malate dismutation—to generate cellular energy during anoxia.
[65, 78] 
To describe the survival of C. elegans in hypoxic environments, it is useful to define 
three ranges of oxygen tension: mild hypoxia (0.25-1 kPa), severe hypoxia (0.01-0.1 kPa), and 
anoxia (<0.001 kPa).  C. elegans embryos have a high rate of survival (>90%) following 
exposure to mild hypoxia for 24 h, and this survival is dependent on the expression of hif-1, a 
homolog of the mammalian hypoxia-induced factor.
[74, 76, 79]  As described above, C. elegans 
embryos also have a high rate of survival (>90%) following exposure to anoxia for 24 h.
[74, 76]  
Survival in anoxia, however, is independent of hif-1.
[76]  Perhaps surprisingly, C. elegans 
embryos have a relatively low rate of survival (<30%) following exposure to severe hypoxia for 
24 h.
[74]  It thus appears that the mechanisms that protect worms during anoxia or mild hypoxia 
are either inactive or ineffective during exposure to severe hypoxia.  Unlike embryos exposed to 
anoxia, embryos exposed to severe hypoxia do not enter a state of suspended animation.
[74, 76, 79]  
Treatment of worms with carbon monoxide during exposure to severe hypoxia, however, does 
induce suspended animation, and also increases the rate of survival for a 24 h exposure 23 
 
significantly.
[74]  These results suggest that, although severe hypoxia alone (without CO 
treatment) is insufficient to induce suspended animation, the suspended state, if induced, can 
protect C. elegans from harm during anoxia or hypoxia.
[74] 
3  How Can Chemists Use the Worm? 
The worm has served predominantly as a model organism for understanding how genes 
specify biological processes.
[80]  The conventional approach, therefore, to studying the worm has 
focused on determining i) the phenotypic effect of a genetic mutation, ii) the interactions among 
different genes and gene products (RNA and proteins), and, ultimately, iii) the function of a 
particular gene.
[38, 80]  One explanation for this strong focus on genetics may be historical: 
Sydney Brenner and his colleagues explicitly developed C. elegans as a model organism to study 
how genes specify organismic development.
[11, 12]  A second, and related, explanation is that 
Brenner selected C. elegans specifically because the organism was amenable to genetic study.  
With the sequencing of the C. elegans genome,
[17] the attractiveness of the worm as a model 
organism for genetics has only increased.  From a chemical perspective, however, a genetic 
mutation is a highly complex molecular perturbation.  A single mutation may have direct 
consequences for the structure and function of the protein for which the gene codes, and may 
also have diverse downstream consequences due to the altered function of the protein.  If the 
gene codes for a regulatory protein, the downstream chemical consequences could be far-
reaching and diverse.  For chemists, therefore, genes may be a much less useful and interesting 
framework for experimental design than “proteins”, “catalysis”, “metabolism”, “networks”, or 
many others.  The relation between the simple information coded in the genome, and the very 24 
 
complex information relevant to understanding life, has grown increasingly obscure as we learn 
more about both genes and life.   
With the overall goal of understanding the relationships between organism-level 
phenotypes and their underlying chemical states, we envision that chemical research with the 
worm would rely on one or more the following experimental strategies: i) modifying the 
chemical state of the worm directly, independently of genetic manipulation, ii) making use of 
genetic mutations that produce simple and well-defined chemical changes (such work could rely 
heavily on the work of geneticists in elucidating the function of genes), and iii) using 
conventional biochemistry and other techniques to monitor the chemical/molecular state of the 
worm in response to genetic, environmental, chemical, and physical perturbations.  The 
following sections provide examples of research with C. elegans that have a significant chemical 
component. 
3.1  Redox Chemistry and the Worm 
Cai and Sesti investigated the effect of chemical oxidation and reduction on behavior and 
aging in C. elegans.
[81]  Treatment of living worms with oxidizing agents such as hydrogen 
peroxide and chloramine-T (sodium salt of N-chloro 4-methylbenzenesulfonamide) diminished 
the ability of worms to perform chemotaxis.  Furthermore, treatment of aging worms with a 
reducing agent, dithiothreitol, slowed the age-related decline in ability to chemotaxis (in 
comparison with untreated worms).  Because of the importance of K
+ channels to neuronal 
function, the authors explored whether the oxidation of KVS-1, a voltage-gated K
+ channel 
expressed in the neurons of the worm, was responsible for the change in behavior.  Mutant 
worms—expressing a version of KVS-1 with a cysteine-to-serine mutation at a single position—25 
 
showed less of a decline in chemotaxis following exposure to chemical oxidants than did worms 
expressing wild-type KVS-1.  This result suggests the oxidation of the cysteine residue of KVS-1 
is partially responsible for the decline in ability to chemotax, and provides a possible mechanism 
by which oxidative stress—from, for example, reactive oxygen species (ROS)—can lead to a 
decline in neuronal function.
[82] 
In the work by Cai and Sesti, ROS appear to act by damaging the function of a protein.  
ROS, however, can also act as signaling molecules in cells.
[83]  A study of C. elegans clk-1 
mutants, which lack an enzyme required for the synthesis of ubiquinone, has provided indirect 
evidence of ROS-mediated signaling in the worm.
[84]  The clk-1 mutants exhibit slower rates of 
development, slower rates of germline development, and longer lifespans than wild-type 
worms.
[84]  These mutants may also have lower levels of ROS than wild-type worms.
[84]  A 
double mutant carrying mutations in clk-1 and sod-1 , which encodes a cytosolic superoxide 
dismutase, had a higher rate of germline development than worms carrying the clk-1 mutation 
only.  Based on the assumptions that clk-1 mutants have decreased levels of ROS, and that 
mutation of sod-1 caused an increase in levels of ROS, the authors concluded that ROS are 
involved in a signaling pathway that moderates the rate of germline development.
[84]  Further 
genetic evidence in the study suggested that the oxidation of low-density lipoproteins by ROS 
may play a role in the  signaling pathway.
[84]  Thus, this study has provided genetic evidence of a 
role for ROS in controlling rates of development.  Further work is needed to confirm the 
existence of an ROS-mediated pathway controlling development, and to determine the 
biochemical interactions that form the basis for such a pathway. 26 
 
3.2  Molecular Mechanisms of Aging in C. elegans 
What is aging?  Is it a programmed process in living organisms (like development)?  An 
accumulation of damage?
[43]  There are many theories.
[85]  Because of its short lifespan 
(2-3 weeks), C. elegans is particularly well-suited for studying aging.  Aging in C. elegans 
involves a number of changes in phenotype, including a loss of reproductive capacity, an 
increase in the disorder of muscle fibers, a wrinkling of the cuticle, and a progressive decline in 
locomotion.  Researchers have discovered over 100 genes that, when mutated, produce an 
increase in the lifespan of worms.
[86]  From a chemical perspective, the fundamental problem in 
the research of aging is to discover what chemical changes in the worm lead to an extended 
lifespan.  It is possible that multiple molecular mechanisms may independently contribute to 
longevity.  Below, we describe three known classes of perturbations that increase lifespan in 
C. elegans: i) mutations in the insulin/IGF-1 signaling pathway, ii) dietary restriction, and 
iii) mutations in genes coding for mitochondrial proteins.
[42]   
3.2.1  Insulin Signaling and Aging 
As described above, inactivation of DAF-2, the sole insulin/IGF-1 receptor in C. elegans, 
increases lifespan.
[69]  The insulin/IGF-1 signaling pathway is involved in the formation of dauer 
larvae under conditions of low food or high population density; daf-2 mutants constitutively 
enter the dauer state during development (daf mutants are so named because of the involvement 
of these genes in dauer formation).
[69]  Long-lived mutants in this group typically exhibit higher 
resilience toward oxidative stress, hypoxia, heavy metals, UV radiation, high temperature, and 
infection by pathogenic bacteria than do wild-type worms.
[42]  The daf-2 mutants also display 27 
 
metabolic changes such as increased storage of glycogen and fat.
[43, 69, 87]  It is unclear, however, 
which, if any, of these characteristics are necessary and sufficient to confer increased lifespan. 
3.2.2  Dietary Restriction, Diet, and Aging 
Many organisms, including mammals, show an increase in lifespan when raised on a diet 
that is reduced in calories, but still contains the nutrients necessary to sustain life.  It is not well 
understood what genetic and molecular-level changes are associated with dietary restriction in 
C. elegans.
[42]  The lifespan of C. elegans depends on the concentration of bacteria in the 
environment in non-monotonic manner.
[88-90]  In the regime of low bacterial concentration 
(~0-10
8 cells/ml), lifespan increases with increasing bacterial concentration, probably because of 
starvation at low bacterial concentrations.  In the regime of intermediate bacterial concentration 
(~10
8-10
10 cells/ml), lifespan decreases with increasing bacterial concentration, possibly because 
of dietary restriction.  At higher bacterial concentrations (>10
10 cells/ml), however, worms die 
during development, possibly because of depletion of oxygen in the environment by bacteria.
[88, 
89]  Because of the apparent detrimental effect of high bacterial concentrations to C. elegans, it 
remains to be determined what ranges of bacterial concentrations correspond to “abundant food” 
and to “dietary restriction.”    
It is possible to use eat-2 mutants—which have reduced pharyngeal function and thus a 
reduced ability to feed on bacteria—as models for dietary restriction.
[91]  The eat-2 mutants have 
extended lifespans, and express higher levels of superoxide dismutase (SOD) and catalase than 
do wild-type worms.
[88, 91]  The extension in lifespan induced by the eat-2 mutation depends 
upon the expression of genes known to play a role in macroautophagy—a cellular process, 
conserved in mammals, in which organelles and sub-cellular components are degraded in 28 
 
lysosomes.
[92, 93]  This process enables cellular components to be broken down and recycled.  The 
eat-2-induced extension in lifespan does not depend on insulin signaling.
[91] 
Bacteria-free, chemically-defined media for C. elegans could, in principle, facilitate a 
greater understanding of how diet is related to longevity and health in C. elegans.
[27]  For reasons 
that are unclear, worms grown in a bacteria-free medium develop more slowly and are longer-
lived than worms grown on bacteria.  In addition, worms grown in bacteria-free medium exhibit 
increased thermotolerance, moderately increased resistance to oxidative stress (treatment with 
hydrogen peroxide or paraquat), and increased levels of SOD and catalase.
[94]  A possible 
explanation is that worms are not able to ingest liquid, bacteria-free medium as well as they 
ingest bacteria; in this scenario, feeding bacteria-free medium to worms would result in dietary 
restriction.
[42] 
Even without chemically-defined media, it has still been possible to examine how diet 
influences longevity by feeding worms bacteria supplemented with specific nutrients.  For 
example, multiple studies have found that the addition of D-glucose to the bacterial diet of 
C. elegans decreases lifespan.
[95-97]  This glucose-mediated reduction in lifespan appears to 
involve the insulin/IGF-1 signaling pathway described above.
[95]   
Treatment of worms with 2-deoxy-D-glucose (DOG)—a competitive inhibitor of 
glucose-6-phosphate isomerase, which is used in the second step of glycolysis—prevents the 
metabolism of glucose.  Schulz and coworkers found that treatment with DOG extends lifespan 
in C. elegans.
[97]  DOG-treated worms also exhibited a higher rate of oxygen consumption than 
untreated worms, and an increased reliance on fat as a source of energy (extracts from DOG-29 
 
treated worms had lower levels of triglycerides than extracts from the control group).
[97]  These 
observations suggest that worms compensate for DOG-mediated inhibition of glycolysis by 
increasing mitochondrial respiration, using fatty acids as a source of energy.  In support of this 
idea, DNA microarray experiments demonstrated that treatment with DOG results in increased 
expression of proteins associated with the transport of lipids, the oxidation of fatty acids, and 
mitochondrial respiration.
[97]   
These results alone do not explain the observed increase in lifespan in DOG-treated 
worms.  A possible explanation is the so-called “hormetic effect”—a phenomenon in which 
exposure to a low dose of a stressor that is toxic at higher doses produces a beneficial result, such 
as increased lifespan.
[98]  In DOG-treated worms, increased mitochondrial respiration could 
increase the production of ROS (the stressor), which, in turn, could elicit a protective response, 
and thus promote longevity.
[98]  To monitor ROS formation, Schulz et al. treated worms with 
2,7-dichlorodihydrofluorescein (H2-DCF), which becomes fluorescent when oxidized to 
2,7-dichlorofluorescein (DCF).  The DOG-treated animals had higher levels of DCF 
fluorescence than untreated worms, suggesting that levels of ROS are higher in DOG-treated 
worms.  Pre-treatment of DOG-treated worms with antioxidants, including N-acetylcysteine (a 
precursor of glutathione), ascorbic acid, and vitamin E, eliminated the life-extending effect of 
DOG.  This observation supports the notion that ROS are responsible for eliciting a protective, 
life-extending response in C. elegans.  The authors also found evidence of a protective response: 
extracts from worms treated with DOG for six days had significantly higher levels of catalase, 
which catalyses the decomposition of hydrogen peroxide, than extracts from untreated worms.
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Other simple changes to the diet of C. elegans can have an effect on lifespan.  For 
example, supplementing the bacterial diet of C. elegans with acetic acid increases lifespan.
[99]  
Although the mechanism of this effect is unknown, it is possible that acetic acid (or acetate) 
interacts with carbohydrate or lipid metabolism to produce this life-extending effect. 
3.2.3  Mitochondrial Mutations and Aging 
Mutations in genes coding for mitochondrial proteins can also increase the lifespan of 
C. elegans.  For example, long-lived clk-1 mutants are defective in the synthesis of ubiquinone, 
which is part of the electron transport chain in aerobic respiration.  Some, but not all, long-lived 
mitochondrial mutants exhibit a lower consumption of oxygen than do wild-type worms.
[42]  One 
theory suggests that chemical damage from ROS is responsible for the process of aging.
[100]  
Reduced mitochondrial activity could result in decreased ROS production.  Disruption of the 
electron transport chain could also stimulate the worm to use anaerobic metabolic pathways, 
such as malate dismutation, which are believed to produce fewer ROS.
[42, 86]  Treatment of 
worms with compounds that have antioxidant activity—including vitamin E and related 
compounds,
[101, 102] ubiquinone,
[102] polyphenols extracted from blueberries and other plants,
[103, 
104]—results in increased lifespan.  It is not clear, however, that the extension in lifespan from 
antioxidants is due to a decrease in ROS—other mechanisms may be responsible.  For example, 
the increase in lifespan produced by polyphenols extracted from natural sources depends on 
genes involved in innate immunity in C. elegans.
[103, 104]  It is also possible that a decrease in 
mitochondrial activity is indirectly responsible for extending lifespan.  Temporary exposure of 
developing larvae to RNAi against proteins in the electron transport chain is sufficient to extend 31 
 
lifespan;
[105] thus decreased mitochondrial activity may serve as a signal that results in permanent 
metabolic changes in the worm.  
3.2.4  Does a Molecular Response to Stress Promote Longevity? 
Many perturbations that lead to increased lifespan in C. elegans mimic some form of 
environmental stress: insulin signaling is closely tied to dauer formation, which is the response 
of developing worms to low food and crowding;
[69] the restriction of calories or glucose imposes 
limits on the intake of energy;
[97] mutations to mitochondrial activity mimic a low-oxygen 
environment;
[42] life-extending natural products—including polyphenols extracted from 
blueberries and polysaccharides extracted from Reishi mushrooms—activate the immune system 
and may thus induce a protective response.
[99, 103, 104]  How does real or perceived exposure to 
stress lead to increased lifespan?  Many long-lived worms exhibit increased levels of SOD and 
catalase, suggesting that removal of ROS increases lifespan.  Although many long-lived worms 
are resistant to oxidative stress, some long-lived worms are hypersensitive to treatment with 
hydrogen peroxide.
[106]  A broader possibility is that environmental stress up-regulates pathways 
for dealing with problematic molecular species: toxic byproducts of metabolism, including ROS, 
xenobiotics, unfolded proteins, and lipofuscin (lipophilic molecular “junk”).
[22]  DNA microarray 
experiments have demonstrated that daf-2 mutants up-regulate groups of genes associated with 
i) the breakdown of problematic compounds (cytochrome P450s, short chain dehydrogenases and 
reductases, UDP-glucuronosyltransferases, and glutathione S-transferases), and ii) the 
maintenance of properly-folded proteins and removal of misfolded proteins (chaperonins, and 
heat shock proteins).
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3.2.5  Outlook for the Research of Aging with C. elegans 
A puzzling aspect of aging research in C. elegans is that long-lived worms have diverse, 
and sometimes conflicting, attributes.  For example, genetic or chemical perturbations can 
produce long-lived worms that have an increased,
[97] decreased,
[107] or unchanged
[88] metabolic 
rate when compared with control worms.  This conflict may reflect a need for standardization of 
experimental methods, but may also reflect the complexity of the aging process.  Another 
complicating factor is the hormetic effect, in which stress plays a counterintuitive role in lifespan 
extension.
[98] 
One area where chemistry could contribute to the research of aging is in the development 
of additional tools for probing the chemical state of the aging worm.  Direct knowledge of 
parameters such as the redox state of the cell, the chemical activity of the mitochondria, and the 
molecular composition of intracellular “junk” would certainly help to sort out the underlying 
molecular basis for aging and longevity. 
Another way forward in the study of aging in C. elegans is the development of new tools 
for research.  In the research of aging, it can be useful to perform longitudinal experiments—
experiments in which the traits of individual organisms are tracked over the lifespans of the 
organisms.  Such experiments can be informative for determining biomarkers of aging in 
isogenic, identically-treated worms because it is possible to track age-related changes in 
phenotype in each individual and correlate those changes with each other, and with lifespan.
[108]  
We developed a microfluidic device for performing longitudinal experiments with C. elegans 
(Figure 2 describes the device).
[109]  The device enables lifelong tracking of a population of 
individual worms in a well-controlled chemical environment, and is compatible with the 33 
 
observation of locomotory behavior and with sub-cellular imaging.  Using this device, we 
identified age-related changes in size and locomotion that correlated with lifespan in 
C. elegans.
[109]   
3.3  Biochemistry and C. elegans 
In comparison with the great amount of research that has been performed using genetic 
approaches to studying C. elegans, there are relatively few reports in the literature that use 
conventional biochemistry to study the worm.
[62, 80]  This subject, clearly, is one to which 
molecular biochemistry could make important contributions.  Although some cite a difficulty in 
obtaining large quantities of individual tissues from the worm as the reason for the relatively 
small number of biochemical studies,
[80] the development of highly-sensitive techniques for 
analyzing small-volume samples (including MS, GLC/MS, and CE/MS) helps to diminish this 
problem.  Others cite the physical barriers created by the cuticle and eggshell of the worm as the 
reason.
[62]  It is possible to overcome these barriers, however, using genetic,
[110] chemical,
[111, 112] 
or mechanical
[112] approaches.  In the following section, we discuss biochemical research with 
C. elegans.  
3.3.1  The Proteome of C. elegans 
Two-dimensional gel electrophoresis, and two-dimensional LC, along with MS have 
enabled the examination of how the expression of proteins differs between populations of worms 
that differ with respect to developmental stage,
[113] sex,
[114] rate of aging,
[115] and reproductive 
capacity.
[116]  In addition, these proteomic techniques have allowed identification of the proteins 
that are present in mitochondria isolated from worms.
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Using isotopes of nitrogen, Krijgsveld and coworkers were able to compare the 
expression of proteins in different populations of worms quantitatively.
[116]  Growing E. coli in 
15N-enriched media, and then feeding those bacteria to worms, enabled the generation of worms 
with 
15N-containing proteins.  It was then possible to combine protein extracts from worms from 
two populations— worms containing 
14N and worms containing 
15N— in a 1:1 ratio, and to 
quantify the relative amounts of 
14N-labeled and 
15N-labeled proteins in the sample using two-
dimensional electrophoresis and mass spectrometry.  This method allowed the determination of 
the relative level of expression of a protein in the 
15N-labeled population of worms using the 
level of expression in the 
14N-labeled population as a reference (and vice versa).   More recently, 
this method facilitated the study of how protein expression changes in a long-lived C. elegans 
mutant.
[115]  Long-lived daf-2 mutants expressed both lower levels of proteins related to lipid 
transport and RNA translation, and higher levels of proteins related to amino acid biosynthesis, 
oxygen metabolism, ROS metabolism, and carbohydrate metabolism, than wild-type worms. 
3.3.2  Monitoring Glycosylation in C. elegans 
Nishiwaki and coworkers used protein immunoblotting to determine that faulty 
morphogenesis of the gonad in a C. elegans mutant was due to disrupted glycosylation of a 
protein involved in guidance of the distal tip of the gonad during development.
[118]  Others have 
used immunoblotting to determine that mutations interfering with the addition (or removal) of 
O-linked N-acetylglucosamine (O-GlcNAc) to (or from) proteins resulted in altered metabolism 
in C. elegans: an increase in levels of glycogen and trehalose, and a decrease in lipids.
[33, 119]  
This result may be relevant to human health; a single nucleotide polymorphism O-GlcNAcase is 
linked to type II diabetes in humans.
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Laughlin and coworkers developed a new way of visualizing glycans in living worms by 
feeding azido-functionalized derivatives of glucosamine, galactosamine, and mannosamine to 
worms.  Over time, the modified sugars are incorporated into glycoproteins.  Copper-free “click 
chemistry” enables the derivatization of the modified sugars with a fluorophore, and thus allows 
the visualization of glycoproteins with fluorescence microscopy.
[120] 
3.3.3  Outlook for Biochemical Research 
The relative lack of biochemical research (in comparison with genetic research) in 
C. elegans may reflect a need for new tools and thus represents an important opportunity for 
chemists in organismic biology and biochemistry.  The ability to probe to the biochemistry of the 
worm will undoubtedly be valuable in understanding how its status at the molecular level 
corresponds to its status at the organismic level. 
3.4  Modeling Human Disease in C. elegans 
It may be possible to use C. elegans to understand some aspects of human disease.
[28]  A 
challenge in developing models of human diseases in C. elegans is to determine the degree to 
which the C. elegans model for a particular disease accurately mimics molecular aspects of the 
disease in humans.  It is likely that studies of diseases that affect processes that are highly 
conserved between worms and humans (such as neuronal signaling or basic metabolism) have 
the most to gain from the use of C. elegans.  Future work will show what commonalities exist.   
Worms allow the study of disease in the context of an intact, multi-organ, multi-cellular 
organism, and may thus be useful in understanding the interaction among multiple biological 
systems in the pathology of a disease.  Worms exhibit a very wide variety of physiological and 36 
 
behavioral phenotypes—ranging from gene expression and biochemical state to behavior and 
aging.  Perturbations to the worm at the molecular level (e.g., mutation of disease-associated 
genes, the addition of drugs) therefore have the potential to produce striking effects at the 
organismic level (e.g., changes in lifespan, morphology, behavior).  For example, it is possible to 
use egg-laying, which is easily observed and quantified, as a readout of serotonergic 
signaling.
[121]  Table 4 provides a list of human diseases for which C. elegans models have been 
proposed and demonstrated.  In some cases, homologs of disease-related genes in humans exist 
in C. elegans.  In other cases, it is necessary to insert human genes into C. elegans to create the 
appropriate model.  For each of the diseases in Table 4, the table lists the associated changes in 
phenotype in the worm. 
3.4.1  Neurodegenerative Diseases 
It is possible to insert genes coding for aggregation-prone polypeptides
[122] into the 
genome of C. elegans, and then observe the effects of the polypeptides on the organism.  This 
strategy has enabled the study of analogs of multiple human neurodegenerative diseases, 
including Alzheimer’s disease (AD)
[123-125] and Huntington’s disease (HD),
[126, 127] in C. elegans. 
In humans, AD is characterized by the aggregation of proteins containing amyloid β 
peptide (Aβ) into plaques or fibrils in the brains of patients, and by severe oxidative damage to 
the tissues of the brain.
[128]  The most obvious altered phenotype in transgenic worms expressing 
Aβ is progressive paralysis.
[123, 129]  These transgenic worms enable monitoring of the formation 
of amyloid plaques (measured histochemically in intact worms) and the presence of carbonyl 
groups in proteins (as a measure of the oxidation of proteins; determined by reacting the 
carbonyl groups in extracted protein with 2,4-dinitrophenylhydrazine, separating the proteins via 37 
 
SDS-PAGE, and detecting the derivatized carbonyl groups with immunostaining).
[123, 125]  
Compared with protein extracts from wild-type worms, extracts from Aβ-expressing worms have 
elevated levels of carbonyl groups.
[125]  Using a temperature-sensitive strain of Aβ-expressing 
worms (which only expressed Aβ when elevated to 23 °C), Drake and coworkers found that 
paralysis and increased levels of carbonyl groups occurred before the onset of plaque 
formation.
[123]  This result suggests that plaque formation may be a symptom of AD, rather than 
solely responsible for the pathogenesis of the disease. 
It may be possible to gain insight into the mechanism of HD pathogenesis using 
transgenic worms expressing polyglutamine (polyQ) expansions.  In C. elegans, animals 
expressing longer polyQ expansions (polypeptides with a higher number of Q repeats) contain a 
higher number of polyQ aggregates, exhibit an earlier onset of polyQ aggregation, crawl more 
slowly, and undergo a more rapid age-related decline in locomotion than animals expressing 
shorter polyQ expansions.
[127]  In addition, the expression of polyQ appears to affect the stability 
of other proteins in C. elegans.
[126]  It is possible to generate temperature-sensitive mutations in 
C. elegans in which a mutant phenotype is observable at one temperature (the restrictive 
temperature), but not at another temperature (the permissive temperature).  For example, a 
mutation could lead to a temperature-dependent defect in the folding of a protein; in this case, a 
change in phenotype (due to misfolding) would only occur at restrictive temperatures.  In mutant 
worms carrying temperature-sensitive mutations in a variety of proteins, co-expression of polyQ 
expansions resulted in the exhibition of the temperature-sensitive phenotype at permissive 
temperatures.  For example, worms carrying a temperature-sensitive mutation in paramyosin 
develop normally at 15 °C (the permissive temperature), but arrest growth during development at 38 
 
25 °C (the restrictive temperature).  When worms with this mutant background also carried genes 
coding for polyQ repeats, nearly half arrested growth during development at 15 °C.  This result 
indicates that the presence of polyQ (and possibly the formation of polyQ aggregates) mimics the 
effect of the restrictive temperature.  The authors of this study suggested that the formation and 
buildup of polyQ aggregates may overwhelm the cellular machinery for folding proteins, and for 
correcting or clearing misfolded proteins, and thus polyQ aggregation may amplify the instability 
caused by temperature-sensitive mutations.
[126]  This hypothesis, though untested, would provide 
a universal mechanism for the cellular toxicity associated with aggregation-prone polypeptides 
and proteins. 
3.4.2  Cancer 
During development, hermaphrodites produce exactly 1090 somatic cells.  At different 
points during the developmental process, 131 of these cells undergo apoptosis, leaving behind a 
total of 959 cells in the fully developed worm.  The number of somatic cells in the adult worm 
remains fixed at 959; the cells of the adult worm do not undergo further mitotic division.  These 
non-proliferative cells do not give rise to somatic tumors.
[130]  It may therefore appear that the 
worm is an unlikely candidate as a model organism for understanding cancer.  Three approaches, 
however, have facilitated the development of models for studying cancer and carcinogenesis in 
C. elegans. 
The first approach focuses on the discovery of genetic changes that result in unchecked 
proliferation of cells in C. elegans.  Mutation of the C. elegans gene gld-1 results in worms with 
a tumor-like proliferation of cells in the gonad.  In these mutants, uncontrolled mitotic division 
of germ cells replaces the production of oocytes from the germ cells by meiosis; this 39 
 
proliferation can rupture the gonad and, eventually, the worm.
[131]  Kenyon and coworkers found 
that mutations that extend lifespan in C. elegans—including daf-2 (part of the insulin/IGF-1 
signaling pathway), eat-2 (a mutation that imposes dietary restriction), and clk-1 (a mutation that 
disrupts cellular respiration)—reduce the proliferation of germ cells in gld-1 animals, and, in 
some cases, prevent early death.
[131, 132]  In worms carrying mutations in gld-1 and daf-2, 
apoptosis contributes to the a reduction in the total number of germ cells.
[131]  Unlike apoptotic 
events during development, apoptotic events that reduce the number of germ cells are dependent 
on CEP-1, a homolog of the human tumor suppressor protein p53.
[131]  This result suggests that 
there may be some—albeit distant—relationship between the formation of tumors in humans and 
worms. 
The second approach focuses on the study of pathways that are relevant to human cancer 
and are conserved between humans and worms.  The RAS genes code for a family of small 
GTPases that play a key role in an evolutionarily conserved signaling pathway involved in 
cellular proliferation, differentiation, and survival. 
[133]  Dysregulation of the RAS pathway is 
known to play a role in tumorigenesis.  Approximately 20% of all human tumors contain 
activating mutations in one of the RAS proteins.
[133]  The RAS signaling pathway is highly 
conserved in humans and worms, although in worms, the pathway is simpler; for example, 
worms have a single RAS protein (LET-60), while humans have three.
[134] 
Research with C. elegans enabled significant breakthroughs in the elucidation of the RAS 
signaling pathway.
[135, 136]  An enabling element of this work was that alterations to the RAS 
pathway generate easily observable phenotypic changes in vulval development in the worm: 
mutations that prevent activation of the C. elegans RAS protein produce a vulva-less worm; 40 
 
mutations that cause the RAS protein to be constitutively active produce a multi-vulva 
phenotype.
[134]  In addition, the descendents of only three cells form the vulva in wild-type 
C. elegans.
[134]  The effects of alterations to RAS signaling on the fates of cells in the 
development of the vulva are therefore straightforward to observe.  In addition to serving as a 
simple model for understanding the mechanism of RAS signaling, C. elegans may also serve a 
model for the development of drugs that interfere with RAS signaling.  Inhibition of the RAS 
signaling pathway is a potential direction for anti-cancer therapies.
[133] 
The third approach focuses on studying the mechanism of action of carcinogenic 
compounds.  A carcinogen can contribute to the growth of tumors by i) altering the DNA of a 
cell to initiate tumor formation, or ii) interacting with the cellular machinery in a way that allows 
problematic, tumorigenic cells to persist and proliferate.
[137]  One mechanism of tumor 
proliferation is the inhibition of apoptosis.
[138]  Although it is unclear to what degree the 
inhibition of apoptosis in C. elegans relates to carcinogenesis in mammals, there is a significant 
overlap between the apoptotic pathways in humans and in worms.
[139]  Because both the number 
of cells that develop, and the number of cells that undergo apoptosis are invariant in the worm, it 
is possible to perform an assay for the inhibition of apoptosis simply by counting the number of 
“extra” cells in the developed worm.  Using this approach, Kokel and coworkers examined the 
capacity of different compounds to inhibit apoptosis in worms carrying a partial loss-of-function 
mutation in ced-3, a gene coding for an apoptosis-promoting caspase (ced = cell death).
[130, 140]  
Upon reaching maturity, ced-3 mutants carry a small number of extra cells (in wild-type worms, 
16 cells in the anterior pharynx undergo apoptosis; in ced-3 mutants, 1-2 of these cells persist).  
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persisting cells in ced-3 mutants—that is, they further suppressed apoptosis in these animals.  
Mesitylene (1,3,5-trimethylbenzene), cyclohexane, and camphor did not increase the number of 
extra cells.
[130, 140]  Scheme 1 compares the chemical structures of these compounds.   
A challenge in determining mechanisms of carcinogenesis is that the metabolic 
breakdown of a compound may produce many different reactive species, one or more of which 
may be carcinogenic.  For example, the lower panel of Scheme 1 shows a partial overview of the 
compounds that are produced in the metabolism of naphthalene in humans; the reaction scheme 
shows pathways that lead to reactive species, such as quinones and arene epoxides.
[141]  Reactive 
metabolites can produce carcinogenic effects by bonding covalently with biomolecules (such 
as proteins or DNA), or by generating oxidative stress.
[142]  Using a set of genetic mutants in 
combination with the apoptosis assay, Kokel et al. determined that the likely target of the 
apoptosis-inhibiting compounds was the CED-3 protein.
[140]  In vitro experiments demonstrated 
that although naphthalene does not reduce the activity of CED-3 (or its human counterpart, 
caspase-3), naphthoquinone—a metabolite of naphthalene
[141] (see Scheme 1)—does.
[140]  
Quinonic derivatives of benzene and toluene also reduced the activity of human caspase-3 in 
vitro.
[130]  Although there are still uncertainties regarding the mechanism by which the 
compounds in Scheme 1 inhibit apoptosis—additional metabolites and biological targets may be 
involved
[141, 142]—this work demonstrates the potential usefulness of C. elegans as a simple 
model organism for deconstructing how different classes of compounds interact with the 
apoptotic machinery.
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3.4.3  Drug Discovery Using C. elegans 
The ease with which very large populations of worms can be produced and manipulated 
makes C. elegans potentially useful in high-throughput screens for drug development and 
discovery.
[28]  An important consideration in drugs screens is the bioavailability of compounds to 
C. elegans—for compounds to reach potential drug targets, it is necessary that they first 
physically enter the body of the worm.  The cuticle and intestinal lining of the worm present a 
significant physical barrier to many chemical species.
[143]  One possible strategy to address the 
selective permeability of the cuticle is the development of mutant strains of C. elegans that have 
compromised cuticles, but are otherwise healthy;
[110] this strategy, however, has not been 
adopted. 
To characterize the bioavailability of a large group of molecules to the worm, Burns and 
coworkers measured the degree of accumulation of over 1000 drug-like compounds and their 
metabolites within the body of C. elegans.
[143]  Scheme 2 shows the five most common structural 
motifs in molecules that did accumulate in C. elegans, as well as the five most common motifs in 
molecules that did not accumulate.  Nearly half of the bioaccumulating compounds contained 
one of the structural motifs shown in the left column of Scheme 2, and nearly half of the non-
accumulating compounds contained one of the motifs shown in the right column of 
Scheme 2.
[143]  Burns and co-workers developed a computer-based model for predicting whether 
or not compounds will accumulate in C. elegans on the basis of molecular structure.  This model 
is freely available.
[143]  This work will help to prioritize which molecules are tested in worm-
based screens, and thus increase the likelihood of finding hits using C. elegans. 43 
 
3.5  C. elegans as a Model for Parasitic Worms 
One niche in human health where C. elegans may be particularly useful is in the study of 
parasitic worms.  Parasitic worms, or helminths, include nematodes (roundworms) and 
platyhelminths (flatworms—flukes and tapeworms).
[144]  Although C. elegans is not parasitic, it 
is related to parasitic worms evolutionarily,
[145] and may therefore be a useful model organism 
for understanding the biology of helminths, and for developing anthelminthics—drugs to treat 
parasitic worm infections—and vaccines.
[146, 147] 
The relevance of C. elegans to parasitic species is an important consideration.  Draft 
genomes for several species of human-infecting helminths (including the nematode Trichinella 
spiralis, the filarial nematode Brugia malayi, the tapeworm Taenia solium, and the blood flukes 
Schistosoma mansoni and Schistosoma japonicum
[145]) have enabled genetic comparison.  
Although there are genetic differences—notably in genes relating to parasitism
[148]—it appears 
that, overall, C. elegans is as similar to parasitic worms as parasitic worms are to each other.
[146, 
147, 149]  For the development of broad-spectrum anthelminthics, C. elegans may, therefore, be 
just as relevant as any worm.
[146]  The relatively close evolutionary relationship between 
C. elegans and parasitic worms, along with the striking similarities between C. elegans and other 
worms (especially other nematodes) with respect to body plan and developmental progression, 
suggest that genes in different species that overlap in sequence are likely to overlap in function 
as well.
[147]  Functional overlap is important: for example, in anthelminthic development, it will 
be advantageous if candidate drugs have the same physiological effects in C. elegans and in 
parasitic worms.  44 
 
3.5.1  Helminthic Infection: a Neglected Disease 
More than 2 billion people worldwide are infected with parasitic worms; these infections 
are a significant cause of morbidity and mortality in humans, particularly in the developing 
world.  The three most common helminthic infections worldwide are from Ascaris lumbricoides, 
whipworm (Trichuris trichiura), and hookworm (Necator americanus and Ancylostoma 
duodenale).
[150]  These worms are of greatest prevalence in developing regions of Africa, Asia, 
and Latin America.
[144]  Table 5 lists the most problematic species of parasitic worms for 
humans with respect to the number of people infected. 
Moderate to severe helminthic infections produce a dramatic decline in quality of life for 
the infected person.  The severity of infection corresponds to the number of worms with which a 
host is infected.
[144]  Infections can cause malnutrition (including anemia, vitamin deficiencies, 
and protein loss), permanent damage to tissues, stunted growth, reduced fitness, and impaired 
cognition and memory.
[144]  In pregnant women, helminthic infections increase the likelihood of 
maternal death during pregnancy or childbirth, and also cause premature births and low 
birth-weights for newborns.
[144]  Some species of worms disable the host severely: lymphatic 
filariasis, caused by infection with filarial nematodes, produces extreme swelling of the legs and 
genitals; onchocerciasis, caused by infection with the nematode Onchocerca volvulus, can cause 
blindness.
[144]  In addition, helminthic infections appear to increase the transmission, and 
enhance the progression, of other diseases, including HIV/AIDS and malaria.
[144]   
Despite the fact that helminthic infections are one of the most common clinical 
conditions in humans, there are relatively few available anthelminthics.
[151]  
Benzimidazole-derived compounds (mebendazole and albendazole), pyrantel pamoate, and 45 
 
ivermectin are broad-spectrum anthelminthics.  Diethylcarbamazine is used for some filarial 
nematodes, and praziquantel and oxamniquine are used for schistosomes.
[152]  Scheme 3 shows 
the chemical structures of these compounds.  Anthelminthic drug resistance—a significant and 
widespread problem in animal husbandry
[152]—is appearing in worms that infect humans.
[144]  
The practice in resource-poor areas of controlling helminthic infections by administering a single 
drug periodically to all members of a population or sub-population (e.g., school-children)
[144, 151] 
may be contributing to the growing problem of anthelminthic resistance.
[144, 152, 153]  There is, 
therefore, a clear and urgent need to increase the number of available treatments for helminthic 
infections.   
3.5.2  C. elegans: a Model Parasite? 
Research of helminths faces two significant challenges.  First, research of helminths 
receives much less funding than other globally-important health issues.  Figure 3 summarizes 
how global investment in research and development for neglected diseases was divided in fiscal 
year 2008.  Funding for helminthic research represented 2.3% of global investment.
[154]  
(Combined, research of HIV/AIDS, malaria, and tuberculosis received >70% of the total 
investment.
[154] )  Second, because parasitic worms cannot be cultured without a host organism, it 
is difficult and expensive to work with parasitic worms.  Because C. elegans is easy and 
inexpensive to work with, it may help to surmount both of these challenges. 
The principal benefit that C. elegans offers as a “model parasite” is experimental 
tractability.  The biological, chemical, and physical tools and techniques that have been 
established for C. elegans are not easily transferrable to the research of parasitic worms.
[155]  The 
lifecycles of parasitic worms are often complicated and involve one or more host organisms.
[148]  46 
 
Parasitic worms typically live outside of a host for only part of their developmental cycle 
(hookworms, for example, live outside a human host only as embryos and early-stage larvae
[151]) 
and are thus not accessible at all developmental stages.  Because of the difficulty in making 
simple phenotypic observations for worms within a host, phenotype-based assays are limited to 
those developmental stages where the worm can live outside the host.
[156]  In addition, because 
there are not methods for culturing parasitic worms without a host, it is not possible to generate 
and maintain isogenic stocks of mutants for parasitic worms.  In contrast, with C. elegans, 
observing worms at different stages of development, and maintaining isogenic stocks of mutants, 
are straightforward tasks.  The great amount of accumulated knowledge for C. elegans also 
contributes to its usefulness in helminth research.  The existence of a well-annotated genome for 
C. elegans has been instrumental in the identification of genes and their functions in the genomes 
of parasitic worms.
[157-159] 
3.5.3  C. elegans and the Development of Anthelminthics 
C. elegans has already played a valuable role in elucidating molecular aspects of 
anthelminthic activity and resistance.  Genetic work with C. elegans demonstrated that 
benzimidazole and related compounds act by disrupting the assembly of β-tubulin into 
microtubules.
[160]  Later, Kwa and coworkers isolated β-tubulin genes from 
benzimidazole-sensitive and benzimidazole-resistant populations of the sheep-infecting 
nematode Haemonchus contortus.  The principal difference between genes from sensitive and 
resistant populations was the replacement of phenylalanine with tyrosine at position 200 of the 
predicted amino acid sequence in genes from resistant worms.
[156]  After confirming that it was 
possible to express functional β-tubulin from H. contortus in C. elegans, the authors 47 
 
demonstrated that mutation from Phe to Tyr at position 200 in the parasite-derived β tubulin was 
sufficient to generate resistance to benzimidazole in C. elegans.
[156] 
Kaminsky and coworkers used C. elegans to determine the mechanism of action of a new 
class of potential anthelminthics—amino-acetonitrile derivatives (AADs).
[161]  Screens in 
parasitic larvae, and in worm-infected non-human mammals (mice and sheep), identified several 
AADs as candidate drugs.  Exposure of C. elegans to the compounds produced a combination of 
phenotypes—hyper-contraction of the body muscles, spasmodic contractions of the pharynx, 
defective molting, and necrotic cell death—not seen in response to existing anthelminthics.  It 
was also possible to test the ADDs in strains of C. elegans that are resistant to ivermectin, 
benzimidazole, and levamisole.  These worms were still sensitive to AADs.  These results 
suggested that the mechanism of action of the AADs is distinct from that of existing 
anthelminthics.  A forward genetic screen identified AAD-resistant C. elegans mutants, which 
carried mutations in a specific sub-family of nicotinic acetylcholine receptors (nAChRs).
[161]  
Importantly, the authors were able to verify the relevance of this mechanism for parasitic worms 
by selecting for AAD-resistant larvae of H. contortus.  PCR confirmed that AAD-resistant 
H. contortus carried mutations in an nAChR that was homologous to one of the receptors 
identified in C. elegans.
[161] 
How else might C. elegans assist in the research of parasitic worms?  C. elegans may 
facilitate the identification of new molecular targets for anthelminthic development by 
simplifying the determination of the function of potential targets.  To be effective, anthelminthic 
drugs must produce a physiological change in the worm that results in either the death of the 
worm (directly or indirectly) or the expulsion of the worm from the host.
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anthelminthics elicit a variety of physiological effects, including interference with microtubule 
formation (benzimidazole), paralysis of the pharynx (ivermectin), and inhibition of the synthesis 
of nucleic acids (oxamniquine).
[152]  By examining the function in C. elegans of proteins that are 
conserved among worms, it may be possible to identify promising targets for drug 
development.
[158, 162, 163]   
3.5.4  Parasite-Host Interactions 
Parasitic worms have evolved protective strategies to evade, and even control, the 
immune response of the host.
[164]  Within the host, worms release molecules that can either block 
activities of the immune system directly, or modulate the activity of the immune system by 
interfering with signaling pathways.
[164]  For example, parasitic worms release cystatins—
cysteine protease inhibitors—that disrupt the presentation of antigens and thus prevent the 
proliferation of T cells.  Cystatins also modulate cytokine signaling in the host.
[164]  Compounds 
secreted by parasites also appear to down-regulate macrophage activity, up-regulate the 
production of NO, which inhibits the growth of lymphocytes.
[164]  The ability of parasites to 
modulate the immune system allows parasitic infections to persist for years.  (Interestingly, 
inoculation of humans with hookworm appears to be an effective treatment for Crohn’s 
disease—an inflammatory disease of the gut.  It is possible that the therapeutic effect is mediated 
by the suppression of immune activity by the parasites.
[165])   
Although C. elegans is a free-living worm, it may facilitate an improved understanding of 
parasite-host interactions in helminthic infections.  In humans, parasitic infections elicit a type 2 
immune response—a characteristic set of molecular responses generated by type 2 helper T cells 
(Th2).
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nematode) and C. elegans both produced a type 2 immune response in mice.
[166]  C. elegans thus 
appears to be a relevant model system for unraveling the molecular interactions involved in the 
induction of the type 2 response.  Treatment of mice with fractionated extracts from C. elegans 
suggested that nematode glycoproteins play an important role in generating the characteristic 
immune response.
[166]   
C. elegans research may assist in the development of vaccines against parasitic 
helminths.  Among nematodes, proteins and glycoproteins expressed on the surface of the cuticle 
are highly conserved.
[162, 167]  Such molecules, because they are exposed to the host, are logical 
targets for vaccine development.  The molecules that are expressed on the surface change with 
developmental stage, and also in response to environmental cues.
[167]  The study of temporal and 
spatial patterns of expression of these molecules in C. elegans may help to guide the selection of 
target antigens for vaccine development.
[162]  It may also be possible to express and examine 
parasite-derived antigens in C. elegans.
[168]  
3.5.5  Outlook for Studying Parasitic Worm Infections with C. elegans 
There are, of course, limitations to the usefulness of C. elegans for the study of parasites.  
There may be families of genes and chemical pathways that are exclusively found in parasitic 
worms (although through comparative studies, C. elegans, as a model free-living worm, may 
help elucidate what biological processes are necessary for parasitism).
[146, 148]  In addition, it will 
always be necessary to validate that a result obtained in C. elegans is relevant in parasitic 
species.  Validation, however, is a simpler experimental task than discovery. 50 
 
The ease with which C. elegans can be adopted in the laboratory should encourage and 
enable chemists to undertake research with relevance to helminth biology.  C. elegans may also 
be an experimental stepping-stone for chemists interested in working with parasitic worms.  
Overall, C. elegans offers chemists an excellent entry point into studying one of the world's most 
important classes of pathogens. 
4  What Tools for Studying the Worm Are Available to Chemists? 
Research that seeks to relate chemical details to biological and organismic phenomena in 
C. elegans will require tools for measuring organismic phenotypes, tools for measuring 
molecular phenotypes, and tools for applying chemical, physical, and biological perturbations to 
worms.  This section describes such tools.  We place particular emphasis on microfluidic tools, 
which are becoming popular in C. elegans research.
[109, 169-198] 
4.1  Microfabricated Tools for Manipulating and Confining Worms 
Microfluidic devices have four principal features that make them useful for C. elegans 
research: i) they are compatible with the application of a broad range of stimuli, and the 
observation and quantification of a broad range of phenotypes; ii) they create well-defined 
environments for worms, and can thus reduce variability in experiments due to subtle changes in 
the chemical and physical environment; iii) they are either scalable (and thus enable the 
observation of many worms in parallel) or high-throughput (and thus enable the observation of 
many worms in rapid succession) and should therefore facilitate the collection of statistically 
meaningful data; and iv) they have features of the appropriate size for worms: adult worms are 51 
 
approximately 1 mm in length and 50 µm in width, and channels with these dimensions are 
straightforward to generate.
[199, 200] 
In the laboratory, worms typically live on the surface of agar in agar-filled Petri dishes 
(Figure 1a).  A layer of bacteria on the surface of the agar provides a source of food for the 
worms.  While it is possible to make simple (and useful) observations of worms in this 
environment, many experiments require more detailed examination.  Fortunately, a number of 
tools facilitate observation of the worm through physical confinement of its body. 
A number of new tools for studying the worm are microfluidic devices fabricated in the 
elastomer poly(dimethyl siloxane) (PDMS) using soft lithography.
[199, 200]  PDMS is a useful 
material for constructing these devices because it is transparent down to 230 nm—and is thus 
compatible with conventional light microscopy—and because is it non-toxic and transparent to 
gases—and is thus compatible with living organisms.
[200]  C. elegans is capable of living on 
hydrated surfaces exposed to air, or submerged in liquid.  PDMS-based devices and tools for 
studying the worm can therefore consist of air-filled microchannels resting on an agar 
substrate,
[181, 190] or closed microchannels that are filled with fluid .
[173, 184, 192] 
4.1.1  Immobilization and Imaging of Worms in Microfluidic Devices 
For many experiments with C. elegans, it is desirable to immobilize live worms without 
harming them.  The principal motivation for immobilization is to ease, or enable, the observation 
of tissue-level, cellular, and sub-cellular phenotypes in intact worms, including, but not limited 
to, i) the morphology of tissues (e.g., muscles, organs) within the body of the worm, ii) the level 
of expression and localization of proteins, as monitored using genetically-encoded fluorescent 52 
 
reporters (e.g. GFP),
[201] iii) the activity of neurons, as monitored using fluorescent indicators of 
changes in intracellular concentrations of calcium,
[202] and iv) the biochemical composition of 
the tissue of the body, as measured using fluorescent organic dyes.  In addition, immobilization 
enables the performance of laser-mediated microsurgery, which is used in C. elegans research to 
ablate specific tissues without inflicting damage elsewhere in the body of the animal.
[203, 204] 
It is possible to immobilize large populations (>1000) of worms simultaneously by 
exposing the animals to paralytic drugs, such as sodium azide (a metabolic inhibitor);
[205] 
however, for certain experiments—the observation of neuronal activity using calcium 
imaging,
[202] for example—it is preferable to use live, non-anesthetized worms.  One solution is 
to use cyanoacrylate glue to immobilize worms on an agarose pad; this approach has enabled 
FRET-based calcium imaging.
[202, 206] 
More recently, a new approach—microfluidic devices fabricated in PDMS—has enabled 
immobilization of the worm.
[172-174, 182, 184, 188, 192, 193, 195, 197]  These devices present a broad range 
of strategies for immobilization.  In general, there exists a tradeoff between simplicity of 
fabrication and operation, and the degree of immobilization that is achieved. 
Chronis and coworkers presented a simple microfluidic tool, which they call a worm trap, 
for immobilizing worms.
[173, 195]  The trap consists of a single microfabricated chamber that is 
slightly larger in width than the diameter of the worm, and slightly smaller in depth than the 
diameter of the worm.  The worm is able to generate forward and reverse body waves that 
resemble the body waves in freely crawling worms, but because the device compresses the body 
of the worm slightly in one dimension, the worm cannot generate any net displacement.  The 53 
 
immobilization effected by the trap is sufficient to enable calcium imaging in individual neurons.  
In addition, because a worm within the trap has (limited) motility, it is possible to correlate 
neuronal activity with locomotory behavior.   
Our laboratory has developed a device containing an array of microfluidic worm 
clamps—tapered channels, into which single worms can be loaded and physically 
immobilized.
[184]  Figure 4a shows the design of the device and a photomicrograph of worms 
immobilized within the device.  To operate the device, it is necessary only to add a suspension of 
worms to the inlet of the device and to apply suction to the outlet; the geometry of the device 
automatically distributes a single worm to each clamp.
[184]  A version of the device with 
128 clamps enables the simultaneous immobilization and observation of over 100 animals.  The 
worm clamps have proven useful for the immobilization of worms for laser-mediated ablation of 
neuronal axons
[180] and synapses.
[169]  In these experiments, the clamps also enabled time-lapse 
imaging of neuronal growth in immobilized animals.
[169, 180]  Using a similar strategy for sorting 
worms, Stirman and coworkers developed a microfluidic device that automatically distributes 
worms into individual channels in which they are partially immobilized (as with the worm trap, 
above).  This device enabled the observation and quantification of the neuromuscular activity of 
many worms simultaneously.
[198] 
Other non-invasive, microfluidic methods of immobilization include the use of 
suction,
[192] compression,
[172, 182, 188] and combined suction and compression.
[193]  Figure 4b-c 
illustrates these approaches.  These approaches immobilize worms sufficiently for laser-mediated 
microsurgery and sub-cellular imaging.
[182, 192, 193]  Krajniak and coworkers used Pluronic 
F127—a block copolymer than undergoes a reversible sol-gel transition near room 54 
 
temperature—to immobilize worms reversibly in a microfluidic device by flowing a liquid 
solution of the polymer into worm-containing chambers, and then raising the temperature to 
solidify the polymer in place around the worm.
[197] 
Although physical immobilization prevents the bodies of the worms from moving, it does 
not prevent motion of structures inside the body of the worm—the muscles along the wall of the 
body and the pharyngeal muscles are still able to contract.  This feature could be beneficial if, for 
example, one was interested in observing the motion of the pharyngeal muscles.  Exposure to 
low temperature (4 °C) and treatment with carbon dioxide both induce complete paralysis in 
C. elegans.  It is therefore possible to immobilize worms by introducing a second layer of 
microfluidic channels—directly above the channels containing worms—and flowing either liquid 
coolant
[174] or gaseous CO2
[172] through this second layer.  An added benefit of immobilization 
with CO2 is that the removal of oxygen from the system reduces the rate of photobleaching for 
fluorescent markers within the worm.
[172, 207] 
In contrast to the method of gluing worms described above, the microfluidic methods for 
immobilization described above are all reversible.  These devices therefore allow the release of 
worms from immobilization for further analysis.  We observed that worms that were recovered 
from the 128-clamp device following immobilization exhibited lifespans similar to worms that 
had not been immobilized.
[184]  Following immobilization, it is possible to use on-chip pneumatic 
valves
[208] to sort worms based on phenotype—determined during immobilization—into different 
down-stream reservoirs for further observation on-chip,
[192] or off-chip.
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As an alternative to observing worms and other objects with conventional microscopy, 
Yang and coworkers developed an “optofluidic microscope”—a lens-free method of imaging 
worms using a microfluidic channel mounted directly on top of a CCD or CMOS sensor 
array.
[179, 183]  The simplest method of imaging an object without a microscope using a CCD or 
CMOS array is to record a direct projection of the object on the array.  With this method, the 
resolution of the resulting image is limited by the dimensions of the pixels in the sensor array.  
Yang and coworkers found a method of overcoming this limit in resolution.  In the optofluidic 
microscope that they developed, a thin layer of metal prevents light from reaching the sensor 
array in all areas except for a row of small holes (≤1 µm in diameter) in the metal, diagonally-
arranged across the floor of the microfluidic channel.  In the direction perpendicular to the length 
of the channel, the holes are offset by half their diameter.  In the direction along the length of the 
channel, the holes are spaced such that each hole is associated with a unique pixel on the sensor 
array.  With this geometry, after an object flows along the length of channel and across the 
diagonal row of holes, it is possible to reconstruct an image of the object based on the signal 
from the sensor array.
[179, 183]  In this arrangement, the size of the holes, and not the size of the 
pixels, determines the spatial resolution.  One limitation of the optofluidic microscope is that it 
cannot image moving objects—it is necessary to paralyze worms before imaging them.  The 
device can, however, image worms at a relatively high rate—up to 40 worms min
-1.
[183] 
A commercial instrument is available for rapidly screening and sorting worms based on 
phenotype: the COPAS™ Biosorter (Union Biometrica, Holliston, MA) enables flow cytometry 
to be performed on large objects, including worms.
[209]  The COPAS™ system can measure 
optical density and multicolor fluorescence intensity as a function of length along the body of a 56 
 
worm, and can thus identify tissue-level changes in phenotype.  Although the spatial resolution 
achieved using the COPAS
TM system is not as high as the resolution that is achievable with 
standard microscopy, this automated system can collect phenotypic data for populations of tens 
of thousands of worms.
[209] 
4.1.2  Confinement of Worms in Microfluidic Devices 
In addition to tools for immobilizing worms, there also exist a variety of microfabricated 
devices for confining worms in a microfluidic environment without completely immobilizing 
them.  It is possible to divide these devices into two general categories: i) devices that house 
single worms in individual chambers
[109, 172, 188, 192, 197] or droplets,
[176, 177, 196, 210-212] and ii) 
devices that house worms in “arena-style” chambers—single chambers containing multiple 
worms.
[170, 171, 181, 187, 189-191, 194, 195]  Figures 2 and 5 provide examples of these devices.  
Confinement within a microfabricated or microfluidic device enables the observation of 
organism-level traits, principally behavior and survival.  In C. elegans, behavior encompasses 
locomotion, feeding, defecation, egg-laying, and, if males and hermaphrodites are present, 
mating.
[59]  It is possible to observe all of these behaviors, as well as survival, in worms in a 
microfluidic device. 
Microfabricated devices can restrict the location of a population of worms to within the 
field of view of a microscope objective.  This restriction enables the observation of the whole 
population simultaneously.  It is then possible to track the behavior of the population over time.  
Continuous recording of the worms can enable the tracking of individuals in arena-style 
chambers using automated tracking software
[213] (although interruptions in recording or 
collisions between worms can result in the loss of the identities of the worms).  The strategy of 57 
 
confining worms within a fixed field of view in a microfluidic device facilitated the cultivation 
and observation of C. elegans in space.
[185, 186]  Devices that house individual worms in chambers 
and droplets enable the maintenance of the identities of individual worms over extended periods 
of time without tracking software.  We developed a microfluidic device for the maintenance of 
single worms within individual chambers for their entire adult lifespans
[109] (see Figure 2).  The 
device allowed us to determine relationships between age-related changes in locomotion and 
body size with ultimate lifespan.
[109]  Droplet-generating devices enabled researchers to raise 
single worms from the embryonic stage to adulthood within individual droplets.
[177, 196] 
Several research groups have combined chambers for confinement and mechanisms for 
immobilization in a single device, so that it is possible to monitor behavior and survival within 
the chambers, and then immobilize worms temporarily for imaging at higher-resolution.
[109, 172, 
188, 192, 197]  This approach has enabled the study of the relationship between locomotion and 
neuronal death.
[188] 
4.1.3  Creating Well-Defined Environments in Microfluidic Devices 
Using microfabrication, it is possible create uniform and well-defined environments for 
the worm.  For comparison, Figure 1a shows the conventional environment for C. elegans in the 
laboratory—an agar-filled Petri dish that has been seeded with E. coli.  The chemical and 
physical environment of the Petri dish is not easily controlled.  Moisture from the agar can 
evaporate over time, and the hydration of the agar can affect the behavior of C. elegans.
[205]  In 
addition, the concentration of food on the plate is not uniform; typically, agar plates are seeded 
with bacteria such that there is a lawn of bacteria at the center of the plate that does not extend to 
the edges of the plate.  Moreover, consumption of oxygen by the bacteria may produce non-58 
 
uniform concentration of oxygen at the surface of the agar.
[181]  Worms crawl all over the surface 
of the agar (and sometimes burrow into the agar); because of the non-uniformity in the 
environment of the plate, individual worms may experience changes in environment with time, 
and different worms may experience slightly different environments.  These differences may 
increase animal-to-animal variability in experiments. 
Microfluidic devices enable the generation of well-defined and tunable chemical 
environments.  Microfluidic devices are also compatible with the application of a wide variety of 
physical stimuli.  For example, the concentration of food—a relevant parameter in the research 
of dietary restriction and mechanisms of aging—is not easily modified on an agar plate, but can 
be controlled in the liquid culture of worms in a microfluidic device.
[109]  In addition, in a 
microfluidic device, it is possible to modify the chemical environment of the worm simply by 
switching the composition of the liquid that flows through the device.  Rhode and coworkers 
developed a multiplexed, microfluidic interface for connecting the inlet of a microfluidic device 
to the contents of a multi-well plate.
[192]  Chronis and coworkers exploited laminar flow in 
microfluidic devices to develop a scheme for rapidly switching the chemical environment in the 
vicinity of the nose of an immobilized worm.
[173]  Microfluidics enabled the generation of 
i) spatial gradients of odorants associated with bacteria in air-filled microchannels on agar 
surfaces to facilitate the study of bacterial preferences and memory,
[190, 194] ii) spatial gradients of 
oxygen in air-filled microchannels on agar surfaces to facilitate the discovery and investigation 
of “aerotaxis”—the movement of animals to a specific oxygen concentration—in C. elegans,
[170, 
171, 181, 195] and iii) temporal gradients of odorants in the air flowing over an array of droplets 
containing single worms to facilitate the study of chemotaxis.
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It is possible to exploit the permeability of PDMS to oxygen, nitrogen, and carbon 
dioxide to control the levels of these gases in the environment of the worm.  Devices in which 
liquid-filled channels containing worms and gas-filled channels are separated by a thin layer of 
PDMS allow researchers to control the composition of gases that are dissolved in the liquid 
environment of the worm by changing the composition of the gas flowing through the device.  
This approach has been useful for the immobilization of worms with CO2,
[172] and for the study 
of the neuronal responses of C. elegans to changes in O2 levels.
[195] 
The principal stimuli that have been applied to worms in microfluidic devices are 
dissolved chemical compounds and gases.  Worms exhibit behavioral and biochemical changes 
in response to diverse physical stimuli, including electric fields,
[191, 214] temperature,
[211, 215] and 
ionizing radiation (UV light, protons, gamma radiation, and iron atoms
[216-218]).  It should be 
possible to incorporate these stimuli into microfluidic devices; for example, Rezai and coworkers 
recently used a microfluidic device to examine the locomotion of worms in an electric field.
[191] 
4.2  Tools for Observing Phenotypes 
4.2.1  Observing the Worm with Microscopy 
There are a number of techniques in microscopy that are useful for observing the worm.  
Bright-field microscopy enables observation of lifespan, behavior, and gross morphology.  It is 
possible to image moving worms at high magnification using a microscope with a motorized 
stage and computer program that tracks the center of mass of the worm.  Programs are available 
that track the motion of crawling worms.
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phenotype in C. elegans, and can be an informative readout of neuronal and muscular function, 
survival, and chemotactic behavior. 
Nomarski (differential interference contrast) microscopy enables detailed imaging of 
body structures in C. elegans.  For example, using Nomarski imaging, it is possible to visualize 
every cellular nucleus in the worm,
[13] to identify cellular corpses from apoptosis,
[14] and to 
observe internal motion, such as the rhythmic motion of the pharyngeal muscles, in detail.
[220]  
Polarized light microscopy can also aid in the visualization of certain body structures—for 
example, the ordered structure of the myofilament assemblies of the muscles in C. elegans are 
more easily viewed with polarized light microscopy than with conventional bright-field 
microscopy.
[221]  For specific imaging applications, it is possible to use non-linear optical 
techniques.  For example, coherent anti-Stokes Raman scattering (CARS) enables the imaging of 
lipid stores within the worm without the need for lipophilic dyes.
[222]  Fluorescence microscopy 
enables the visualization of neuronal activity (using FRET-based Ca
2+ dyes
[202]) and gene 
expression (using fluorescent-protein-conjugated proteins).  The use of transmission electron 
microscopy (TEM) to image transverse sections of the worm—sectioned using an 
ultramicrotome—is a classic technique in worm biology.  This technique enabled the 
microscopic reconstruction of the complete nervous system of C. elegans in the 1970s.
[15, 223] 
4.2.2  Chemical and Biochemical Readouts 
Section 3.3 includes a description of the use of HPLC, SDS-PAGE, MS, and 
immunochemistry to identify proteins expressed in C. elegans.  Biochemical techniques have 
also facilitated the identification and characterization of metabolites secreted by the worm.
[224]  
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their environment.  The pheromone serves as a signal of population density; a high concentration 
of pheromone causes C. elegans larvae to enter the dauer larval stage—an alternative 
developmental stage in which growth is arrested.  It is possible to obtain crude dauer pheromone 
by filtering liquid medium that has been used to culture C. elegans.  Chromatography enables 
fractionation the crude pheromone; it was possible to identify fractions containing active 
components of pheromone simply by treating worms with different fractions and determining 
which fractions induced dauer formation
[225] or inhibited exit from the dauer stage.
[224]  Proton 
NMR and LC-MS allowed the identification of the chemical structure of each of the active 
components of the pheromones mixture.
[224, 225]  Scheme 4 shows three active components of 
dauer pheromone.  
Technological advances in the resolving power of solid-state NMR have enabled the 
chemical characterization of complex, inhomogeneous samples.  Blaise and coworkers used 
1H 
high-resolution magic angle spinning NMR spectroscopy to characterize the metabolic profile—
the molecular phenotype—of intact worms.
[226, 227]  The authors used NMR to examine molecular 
differences among three strains of C. elegans: wild-type worms, sod-1 (superoxide dismutase) 
mutants, and ctl-1 (catalase) mutants.
[226, 227]  Both sod-1 and ctl-1 code for proteins involved in 
the elimination of ROS.  Worms carrying mutations in these genes are not distinguishable from 
wild-type worms visually.  Compared with the NMR spectrum for wild-type worms, spectra for 
sod-1 and ctl-1 worms had lower signals for resonances associated with lipids, and also higher 
signals for aldehyde resonances.
[226]  These results are consistent with the idea that in the absence 
of anti-oxidant enzymes like SOD-1 and CTL-1, lipids would be unprotected from oxidation 
from ROS.
[226]  Although it is a relatively new technique,
[226, 227] whole-organism NMR has to 62 
 
potential to be enormously useful in increasing our understanding of molecular-level phenotypes 
in C. elegans. 
4.2.3  Biophysical Readouts 
Pruitt and coworkers have developed tools for measuring the mechanical stiffness of the 
body of the worm,
[228] and for measuring the mechanical forces generated by crawling 
worms.
[229]  These tools may enable the discovery of previously-unobserved phenotypes in 
C. elegans. 
Metabolic rate is an important physiological metric.  There are a number of approaches 
for the determination of the metabolic rate of C. elegans, including the measurement of i) the 
production of CO2 by a population of approximately 50 worms using mass spectrometry,
[230] 
ii) the consumption of O2 by single worms using fluorimetry,
[231] iii) the production of heat by a 
population of worms using microcalorimetry,
[232] and iv) the concentration of ATP in living 
worms using transgenic strains expressing luciferin and luciferase.
[232, 233] 
It is possible to perform both intracellular and extracellular electrophysiological 
recordings of the activity of intact neurons and muscles in C. elegans.  Intracellular recordings 
require that the experimenter dissect a living worm and apply electrodes directly to its internal 
structures—it is a challenging experimental procedure, but enables the collection of quantitative 
data concerning the movement of ions into, and out of, active cells.
[234]  Raizen and Avery 
developed a simple method for performing extracellular recordings of the activity of the 
pharyngeal neurons in C. elegans.
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intracellular recordings with regards to the actual potential of the cells, but are much easier to 
perform.
[234, 235] 
4.3  Genetic Perturbations 
Not all chemists will be interested in learning the techniques of genetic manipulation.  
For those who are interested, C. elegans is a particularly convenient organism for forward and 
reverse genetics.
[38]  Fortunately for those who are not familiar with genetic techniques, there are 
many ways to perform research with mutant animals.  First, it is possible to obtain 
already-generated mutant strains of C. elegans either from other researchers or from depositories 
of mutant strains.  It is important to note that not every gene is represented by a mutation.  The 
Caenorhabditis Genetics Center at the University of Minnesota, a depository of mutant worms 
funded by the National Institutes of Health, has thousands of strains available.  Second, it is 
possible to silence genes in wild-type worms using double-stranded RNA (dsRNA) through 
RNA interference (RNAi).  The experimental procedure for exposing worms to dsRNA is very 
simple; either soaking worms in a solution of the dsRNA or feeding worms E. coli that expresses 
the dsRNA will produce worms with silenced genes.
[236]  Table 2 lists online resources for 
mutant strains of C. elegans and dsRNA against worm genes.  
4.3.1  Genetics and Chemical Genetics 
The approach of chemical genetics may be of interest to researchers with a chemical 
background studying the worm.  It is possible to draw parallels between the approach of 
chemical genetic screening and the more traditional approach of genetic screening.  In a forward 
genetic screen, random mutagenesis creates a population of mutants, which can be screened for a 64 
 
change in the phenotype of interest.  Identification of the mutated gene (or genes) that produced 
the phenotypic change creates a link, either direct or indirect, between the function of the gene 
and the phenotype of interest.  In a forward chemical genetic screen, treatment of the organisms 
with a library of small molecules replaces random mutagenesis.  The success of a chemical 
genetic screen relies upon the assumption that the members of the chemical library are capable of 
altering the activity of proteins in a specific manner.  In principle, a compound from the library 
that produced a change in the phenotype of interest has disrupted a protein whose function is 
related, directly or indirectly, to the phenotype of interest.
[237]  In a reverse genetic screen, the 
creation of a mutation in a gene of interest enables observation of the resulting change in 
phenotype of the organism.  In a reverse chemical genetic screen, in vitro methods identify 
members from a chemical library that bind to a protein of interest.  Treatment of organism with 
small molecules that bind to the protein of interest enables observation of the resulting change in 
phenotype of the organism.
[237] 
Many of the experimental challenges in the approach of chemical genetics are chemical 
in nature.  Typically, the most difficult tasks in a chemical genetic screen are the identification of 
the protein targeted by a small molecule, and the validation that this interaction is specific.
[237]  
These problems are well-suited to a biochemical approach.  An additional challenge in the 
development of appropriate chemical libraries is that an understanding of the relationship 
between chemical structure of small molecules and their ability to bind tightly to proteins 
remains elusive.  The investigation of how to predict and design ligand-protein specificity is an 
important and active area of chemical research.
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5  Summary and Outlook 
5.1  Model Organisms for Chemists: Alternatives to the Worm? 
For some research questions, worms and other multicellular organisms are probably too 
complex.  Unicellular organisms like yeast and E. coli are likely to retain their positions as 
powerful biochemical models.  To study basic intercellular interactions, biofilm-forming bacteria 
(such as Pseudomonas aeruginosa), or slime molds that aggregate into multicellular slugs 
(Dictyostelium discoideum) may be preferable to higher, more complex organisms.  Mycoplasma 
genitalium, a bacterium with the smallest genome—580 kb, coding for fewer than 
500 proteins—of any known free-living organism, has proven useful in the identification of a 
minimal set of genes that are essential for life.
[5]  In 2010, Venter and coworkers transplanted 
chemically synthesized copies of the M. genitalium genome into recipient cells of the yeast 
Saccharomyces cerevisiae.
[239]  This work represents a step towards the chemical specification of 
a living organism. 
In order to make the leap from understanding how an individual cell operates to 
understanding how a human being operates, multicellular model organisms are essential.  The 
real power of C. elegans is that it is the simplest model organism for studying multicellular life.  
C. elegans is simple both in a biological sense—worms are small; they have less than 1000 cells; 
they have a simple body plan—and in a practical sense—maintaining worms is significantly 
easier and cheaper than maintaining either multicellular organisms of higher complexity, or 
mammalian cell cultures.  C. elegans also has many advantages with respect to accessibility and 
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Some other multicellular organisms do have specific features that make them particularly 
useful for specific areas of research.  For example, the puffer fish (Fugu rubripes), has one of the 
smallest genomes among vertebrates, and therefore assists in the identification of the necessary 
genes for vertebrates.
[240]  Frogs (Xenopus spp.) and chickens (Gallus gallus) have large embryos 
that develop outside of the mother, and are convenient organisms for the study of 
development.
[241, 242]  Planaria (Schmidtea mediterranea, and other species) are of special interest 
for the study of tissue regeneration.
[243, 244]  For understanding fundamental questions about the 
nature of multicellular life, however, and particularly for understanding the molecular basis for 
organism-level phenomena, C. elegans appears to be the best of the currently available choices. 
5.2  Relevance of the Worm to Human Health 
Are worms directly relevant to human health?  Research with C. elegans cannot capture 
all aspects of human biology.  There are, however, numerous examples of discoveries made in 
the worm that were informative for human biology.  For example, it was in C. elegans that genes 
regulating aging
[245] and genes regulating apoptosis
[246] were initially discovered.  Later work 
demonstrated that similar genetic pathways exist in humans.
[245, 246]  From a scientific standpoint, 
even in cases where mechanisms of genetic control differ, it will be fascinating to see whether 
the underlying chemistries of organism-level phenomena are preserved across species as diverse 
as worms and humans.  C. elegans has the potential to be a valuable system for understanding 
the underlying molecular mechanisms of human disease, and for testing the activity, and also the 
toxicity, of candidate drugs and treatments.  In order for C. elegans to be useful for screening 
candidate drugs, however, it will be necessary to demonstrate that experimental results in the 
worm are predictive of human outcomes.
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for global human health is the use of C. elegans to gain a better understanding of parasitic worms 
and parasitic worm infections.  Initial work has already shown the usefulness of C. elegans in the 
discovery of new anthelmintic drugs that are effective in mammals.
[161] 
5.3  How Can Chemistry Be Exploited for Worm Research? 
Often the discovery of new biology is driven by new tools.  What additional tools and 
capabilities are needed?  Below, we suggest potential directions for chemists. 
A clear area where chemistry can be exploited for C. elegans research is in the 
development of new tissue- and molecule-specific dyes.  The most commonly-used molecular 
label in C. elegans research is green fluorescent protein (GFP), but there are limits to what GFP 
can do—many cellular compounds are not gene products.  Small organic dyes, which are used to 
label sub-cellular components in in vitro research, are not always usable for research with 
C. elegans because the uptake of the dye can be hindered by the cuticle or the intestinal lining (or 
the eggshell, in the case of embryos).
[201]  This need for useful dyes is an opportunity for 
chemists to explore new strategies for labeling the worm.  The work of Bertozzi and coworkers 
using a combination of modified sugars and “click chemistry” to label glycans is an excellent 
example of how chemistry can be utilized for worm biology.
[120]  To guide the design of new, 
“worm-penetrating” dyes, it may also be useful to characterize the permeability and chemical 
selectivity of both the cuticle and the intestinal lining of the worm. 
Chemistry could provide a new approach in the discovery of new genes.  Over half of the 
genes in the genome of C. elegans have an unknown function.
[248]  These are genes that are not 
orthologous to genes of known function and have not been identified in phenotype-based 68 
 
forward genetic screens.  The best phenotypes for genetic screens are those that can be easily and 
rapidly identified—defects in locomotion or development, for example.  A chemical approach 
could be useful in identifying new mutant phenotypes for genetic screens based on chemical 
reactivity (for example, altered reactivity of the cuticle could indicate a change in the chemical 
composition of the cuticle).  With this strategy, chemistry might enable the identification of new 
classes of mutations.  
A chemical approach could be useful in the continuing development of a bacteria-free, 
chemically-defined medium for C. elegans.
[27]  Worms grown in current formulations of 
bacteria-free medium exhibit slower development than worms that are fed bacteria, suggesting 
that the chemically-defined medium does not have the same nutritive value as the bacterial diet.  
The development of a chemically-defined medium that enables worms to develop as they do with 
a bacterial diet would be useful, and would also be informative with regards to the nutritional 
needs of C. elegans.  It is possible that the nutritive value of the bacterial diet may be due to the 
fact that worms are filter feeders, and therefore the physical state of the food may be important.  
The encapsulation of chemically-defined medium in vesicles or in digestible, bacteria-sized 
beads could potentially increase the ability of C. elegans to ingest the medium. 
Another potential direction for chemists is to examine the effects of simple organic 
reactions in vivo to explore how known chemical reactions interact with living systems.  For 
example, Branda and coworkers treated worms with a photoswitchable molecule—a derivative 
of bis(pyridinium) dithienylethene—that undergoes a reversible, photoinducible switch from a 
colorless, open-ring isomer to a colored, closed-ring isomer.  Switching to the closed-ring isomer 
induced a reversible paralysis in a significant fraction of worms containing the photoswitchable 69 
 
molecule.
[249]  Although the mechanism of the paralysis remains unknown (the authors proposed 
that it could be related to the fact that the closed-ring isomer is more easily reduced than the 
open-ring isomer), this work suggests that exploring how organic chemistry interacts with 
multicellular organisms could be a fruitful direction for chemical research.    
5.4  For What Should Chemists Use the Worm? 
What types of research questions that can be attempted using the worm are likely to be 
interesting to chemists? 
For pharmaceutical research, the worm may be useful for testing the activity and toxicity 
of drug leads in vivo.  While the predictive value of drug testing in worms for activity in humans 
is uncertain, C. elegans is amenable to high-throughput and hypothesis-based screening, and 
would enable candidate drugs to be tested in complex, multicellular organism containing 
multiple cell- and tissue-types.
[250]  It should certainly be possible to study the interaction of 
worms with chemically simple xenobiotics and toxins, such as heavy metals.  Worms may also 
open a window into phenomena—effects of starvation, radiation, increased or reduced 
temperature, vitamin deficiency, anoxia, and reperfusion injury—in which the mechanism of 
injury, and the biological response to it, are likely to be general rather than specific to a 
particular organism.  It is least likely that worms will be useful in studying the effects of 
xenobiotics on specific enzymes, receptors, pathways and systems that are specific to an 
organism or class of organisms. 
Despite the complexity of the worm, it should still be possible to maintain a reductionist 
approach.  The worm should enable chemists to examine the effects that i) very simple molecules 70 
 
(such as O2, H2S, NO, CO, CO2), ii) universal chemical phenomena (ionizing radiation, radical 
formation, formation and management of reactive oxygen species, reduction/oxidation), 
iii) fundamental chemical considerations (kinetics, thermodynamics, stereochemistry, reactivity, 
pH), and iv) basic physical parameters (temperature, pressure) have on life.  
Research with C. elegans has only begun to unravel the mysteries of aging, death, 
behavior, learning, and memory.  We believe that investigating the underlying chemical states 
and reactions that correspond to these processes will be an attractive goal for chemists.   
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Legends for Figures 
Figure 1.  The nematode C. elegans.  (a) In the laboratory, the typical habitat of C. elegans is in 
a Petri dish on the surface of agar that has been seeded with E. coli.  The inset shows a 
population of worms of mixed age.  (b) An adult hermaphrodite crawling on an agar surface. 
 
Figure 2.  A microfluidic device for performing lifelong observation of C. elegans.  (a) A 
schematic diagram of a device with four chambers.  Each chamber houses a single worm for its 
entire adult lifespan.  Upstream of each chamber is a worm clamp—a tapered microfluidic 
channel that enables temporary immobilization of worms for high-resolution imaging.  On-chip 
valves allow each chamber to be isolated fluidically.  The design is scalable—it is possible to 
incorporate more than four chambers into the design.  (b) Photomicrographs of a single worm 
within a microfluidic chamber for its entire adult lifespan.  Continuous flow of suspended 
bacteria from the inlet to the outlet provides food and removes waste.  (c) Photomicrographs of 
the worm from (b) immobilized within the worm clamp on days 3, 5, and 7.  Reversing the 
direction of flow through the device loads worms into the clamps.  This figure was adapted from 
Hulme et al.
[109] 
 
Figure 3.  Summary of global investment in research and development for neglected diseases in 
fiscal year 2008.
[154] 88 
 
Figure 4.  Microfluidic methods for immobilizing C. elegans.  (a) Schematic diagram of an array 
of 128 worm clamps.  This device enables rapid (<15 min), temporary, non-invasive 
immobilization of over 100 worms for high-resolution microscopy and laser-mediated 
microsurgery (adapted from Hulme et al.
[184]). (b) By fabricating a PDMS device with two layers 
of channels separated by a thin membrane of PDMS, it is possible to immobilize worms by 
pressurizing the upper layer of channels with air.  The pressurization deflects the PDMS 
membrane and immobilizes the worm.  This illustration is adapted from Chokshi et al.
[172]  
(c) The application of suction to an array of parallel microchannels pulls the worm against the 
channels, and thus immobilizes the worm.  The left pannel (i) shows the array of microchannels 
for immobilizing worms in the center of the field of view.  Leading to, and away from, this 
region are several valve-controlled microchannels.  These channels enable the introduction of 
worms into the immobilization region, and allow the sorting of worms into channels for either 
waste or collection following immobilization (scale bar: 100 µm).  The right pannel (ii) shows a 
close view of a worm immobilized by suction against the array of microchannels (scale bar: 
10 µm).  These images are reproduced, with permission, from Figure 2 of Rohde et al.
[192] 
(© 2007 National Academy of Sciences, U.S.A.).   
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Figure 5.  Microfluidic chambers and droplets for observing C. elegans.  (a) An array of posts 
provides an environment of “artificial soil” in which worms can crawl.  The device is made of a 
liquid-filled PDMS chamber sealed covalently to glass.  Although the images show only one 
worm, the device enables the observation of the locomotory behavior of several worms 
simultaneously.  The circular posts in (i) and (ii) are 100 µm in diameter; the posts in (iii) and 
(iv) are 200 µm in diameter.  These images are reproduced from Figure 3 of Lockery et al.
[187] 
(used with permission).  (b) A mirofabricated maze for determining bacterial preferences in 
C. elegans.  The device consists of channels embossed in PDMS in conformal contact with an 
agar surface.  The channels are filled with air; worms crawl on the surface of the agar, and are 
confined by the channels.  Zhang and coworkers
[194] placed samples of different bacteria at the 
end of the radial microchannels, placed worm in the center of the device, and observed which 
bacteria the worms preferred.  The image is reprinted by permission from Macmillan Publishers 
Ltd: Nature 438: 179-184, © 2005.  (c) An array of free-standing microdroplets for observing 
locomotion in C. elegans.  By flowing odorant-containing air over the array of droplets, Luo and 
coworkers were able to monitor the temporal dynamics of the locomotory response of worms to 
odorants.  The droplets confined the swimming of the worms to a specific area.  The image is 
reproduced from Figure 1 of Luo et al.
[210] (used with permission). 90 
 
Legends for Schemes 
Scheme 1. Small molecules that do, and do not, inhibit apoptosis in C. elegans.  The lower panel 
shows the formation of reactive, potentially toxic, metabolites in the breakdown of 
naphthalene.
[141]  The metabolic processes involve cytochrome P450 (CYP), epoxide hydrolase 
(EPH), and dihydrodiol dehydrogenase (DDH). 
 
Scheme 2.  Structural motifs associated with molecules that do, and do not, accumulate in 
C. elegans.
[143] 
 
Scheme 3.  Anthelminthics for parasitic worm infections in humans. 
 
Scheme 4.  Three active components of the C. elegans dauer-inducing pheromone.
[224] 
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Tables 
Table 1. Comparing model organisms 
Organism  (+) Advantages and (−) Disadvantages 
Unicellular Prokaryotes   
Escherichia coli
[251] 
  Gram-negative bacterium; lives in gut of 
animals (enteric) 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Straightforward genetic tools exist 
  (+)  Best studied organism 
  (+)  Model for molecular genetics 
  (−)  Limited differentiation 
  (−)  Limited intercellular interaction 
Bacillus subtilis
[252] 
  Gram-positive bacterium; soil dwelling 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Simple model of differentiation and morphogenesis (sporulation) 
  (−)  Some differentiation, but much less than / different from multicellular 
organisms 
  (−)  Limited intercellular interaction 
Mycoplasma genitalium
[5] 
  smallest known free-living bacterium; 
human pathogen 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available   
  (+)  Useful for understanding the minimal set of genes needed by a free-living 
organism 
  (−)  Limited differentiation 
  (−)  Limited intercellular interaction 
Pseudomonas aeruginosa
[253]  
  Gram-negative bacterium; pathogen of 
animals and plants; human pathogen 
(e.g., in cystic fibrosis) 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Model of  bacterial virulence, biofilms, quorum sensing 
  (−)  Limited differentiation 
  (−)  Limited intercellular interaction 
Methanobacterium thermoautotrophicum
[254] 
  archaebacterium; requires only H2, CO2, 
N2 or NH4
+, and inorganic salts; produces 
CH4 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Alternative source of fuel(?) 
  (+)  Unique metabolic processes 
  (−)  Limited differentiation 
  (−)  Limited intercellular interaction 
  (−)  Very different metabolism from higher organisms 
Rickettsia prowazekii
[255] 
  Gram-negative bacterium; genome 
resembles mitochondrial genome; 
obligate intracellular pathogen 
  (+)  Genome is available 
  (+)  Model of bacterial virulence 
  (−)  Difficult to grow (obligate pathogen) 
  (−)  Difficult genetic manipulation 
  (−)  Limited differentiation 
  (−)  Limited intercellular interaction 
Caulobacter crescentus
[256] 
  Gram-negative bacterium; asymmetric 
division produces flagellated cell and 
stalked cell 
  (+)  Inexpensive/easy to grow   
  (+)  Genome is available 
  (+)  Simple model of cellular differentiation and development 
  (−)  Limited intercellular interaction 
Unicellular eukaryotes   
Giardia lamblia
[257] 
  unicellular flagellated eukaryote; free-
living cyst or parasite (mammals) 
  (+)  Genome is available   
  (+)  Model of parasite 
  (+)  Simple model of cellular differentiation 
  (−)  limited intercellular interaction 
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Acetabularia acetabulum
[258] 
  giant unicellular green algae (0.5-10 cm in 
length); well-defined morphology (rhizoid, 
stalk, and cap) 
  (+)  Largest unicellular organism 
  (+)  Simple model of morphogenesis / development 
  (+)  Possible to make grafts of different cells 
  (−)   Very different cell size / body plan from higher organisms 
  (−)  Not amenable to high-throughput screens 
Chlamydomonas reinhardtii
[259, 260] 
  green algae; can grow in the dark; has 
simple visual system (eyespot) 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Model for photosynthesis 
  (+)  Model for vision / evolution of vision 
Dictyostelium discoideum
[261] 
  “social amoeba” or “slime mold”; matures 
from unicellular amoeba to motile, 
multicellular slug, to multicellular, spore-
forming fruiting body 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Model of host in bacterial infection 
  (+)  Model for differentiation and development 
  (+)  Model for chemotactic locomotion 
  (+)  Short life cycle 
  (−)  Very different cellular organization, life-cycle from higher organisms 
Naegleria gruberi
[262] 
  unicellular eukaryote; switches between 
amoeboid and flagellate forms 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available   
  (+)  Simple model of cellular differentiation 
  (−)  Limited intercellular interaction 
Saccharomyces cerevisiae
[263] 
  budding yeast 
  (+)  Simple model of eukaryotic cell 
  (+)  Genome is available 
  (+)  Straightforward genetic tools exist 
  (+)  Simple development (sporulation) 
  (+)  Some intercellular interaction (mating) 
Invertebrate Multicellular Eukaryotes 
Arabidopsis thaliana
[264] 
  fruitless flowering plant 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Lifespan: 6-8 weeks 
  (+)  Best studied plant 
  (−)  Plant physiology differs from animal physiology 
Rotifers
[265] 
  phylum of planktonic metazoans 
  (+)  Inexpensive/easy to grow 
  (+)  Have differentiated organs 
  (+)  Small; ~1000 cells 
  (+)  Invariant development 
  (+)  Transparent 
  (−)  Complex and slow life cycles 
  (−)  Not amenable to high-throughput screens 
  (−)  No transgenic technology exists 
Schmidtea mediterranea
[243, 244] 
  planarian (free-living flatworm); 
regenerates lost body parts; 3-12 mm 
long 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Has organs/differentiated tissues 
  (+)  Simple model of regeneration 
  (+)  Simple model of tissue plasticity 
  (−)  Not amenable to high-throughput screens 
  (−)  No transgenic technology exists 
  (−)  Not amenable to (non-RNAi) genetic manipulation 
Caenorhabditis elegans
[266] 
  1-mm long roundworm; free-living (non-
parasitic)  
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Straightforward genetic tools exist 
  (+)  Short generation time: 2-3 days 
  (+)  Short lifespan: 2-3 weeks 
  (+)  Small; exactly 959 somatic cells 
  (+)  Invariant development 
  (+)  Transparent 
  (+)  Has organs/differentiated tissues 
  (+)  Mutants can be frozen 
 (+)/(−) 50-80% of worm genes homologous to human genes 
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Drosophila melanogaster
[267]  
  fruit fly 
  (+)  Inexpensive/easy to grow 
  (+)  Genome is available 
  (+)  Straightforward genetic tools exist 
  (+)  Short generation time: ~10 days 
 (+)/(−) 50-80% of fly genes homologous to human genes 
  (−)  Mutants cannot be frozen 
Strongylocentrotus purpuratus
[268]  
  sea urchin   
  (+)   Genome is available 
  (+)  Can be fertilized in vitro easily 
  (+)  Transparent embryo; simple larval development 
  (−)  Not amenable to high-throughput screens 
 
Aplysia californica
[269] 
  sea slug 
  (+)   Genome is available   
  (+)  Useful for studying nerve growth, function 
  (−)  Not amenable to high-throughput screens 
  (−)  No transgenic technology exists 
Vertebrate Multicellular Eukaryotes   
Fugu rubripes
[240] 
  Pufferfish 
  (+)  Very small genome for a vertebrate  
  (+)  Genome is available 
  (−)  Produces lethal toxin 
  (−)  Not amenable to high-throughput screens 
  (−)  No transgenic technology exists 
Danio rerio
[270] 
  Zebrafish 
  (+)   Draft genome is available 
  (+)  Small 
  (+)  Embryos are transparent 
  (−)  Long generation time: 2-4 months 
  (−)  Isogenic strains are not available 
Xenopus laevis
[241] 
  Frog 
  (+)  Embryos are large and develop outside of mother  
  (+)  Model for development, teratogenesis 
  (−)  Difficult to manipulate and cultivate 
  (−)  Long generation time: ~ 4 months 
  (−)  Not amenable to high-throughput screens 
Gallus gallus
[242]   
  chicken 
  (+)  Embryos are large and develop outside of mother 
  (+)  Model for development 
  (−)  Difficult to manipulate and cultivate 
  (−)  Long generation time: > 6 months 
  (−)  Not amenable to high-throughput screens 
Mus musculus
[271] 
  Mouse 
  (+)  Genome is available 
  (+)  Strong genetic, physiological overlap with humans 
  (−)  Ethical concerns 
  (−)  Expensive 
  (−)  Long generation time (2-3 months) 
  (−)  Long lifespan 
  (−)  Not amenable to high-throughput screens 
Pan troglodytes
[272] 
  Chimpanzee 
  (+)  Genome is available 
  (+)  Most closely related to humans 
  (−)  Ethical concerns 
  (−)  Expensive/labor intensive to maintain 
  (−)  Long generation time / lifespan 
  (−)  Not amenable to high-throughput screens 
  (−)  Development of transgenic technology carries ethical concerns 
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Table 2.  Resources available to researchers of C. elegans 
Resource  Description 
The WormBook  
http://www.wormbook.org 
An up-to-date online 
reference book for the 
biology of C. elegans.  
Includes an extensive section 
of experimental methods. 
WormAtlas 
http://www.wormatlas.org 
An online database of the 
anatomy of C. elegans, 
including electron 
micrographs of serial 
transverse slices of the body 
of the worm. 
WormBase 
http://www.wormbase.org 
A searchable database of the 
genome and proteome of the 
worm. 
The Kyoto Encyclopedia 
of Genes and Genomes 
http://www.genome.ad.jp/
kegg/kegg2.html 
A searchable database of 
genes for multiple model 
organisms, including worm. 
Reactome 
http://www.reactome.org 
An online database of 
biological pathways for 
multiple model organisms, 
including worm. 
Caenorhabditis 
Research Center 
University of Minnesota 
http://www.cbs.umn.edu/
CGC/ 
An NIH-supported depository 
of mutant worms. 
RNAi Database 
http://rnai.org 
An online database of 
changes in phenotype in 
C. elegans in responses to 
treatment with RNAi. 
Geneservice 
http://www.geneservice. 
co.uk/ 
A vendor of RNAi for 
C. elegans genes, sold in 
library form or as individual 
clones expressed in E. coli 
Addgene 
http://www.addgene.org/ 
Andrew_Fire 
Distributes vector kits 
containing cDNAs for 
fluorescent proteins 
Nematode.net 
http://nematode.net 
An online resource for 
genomic data for parasitic 
nematodes.  Maintained by 
the Genome Sequencing 
Center at Washington 
University in St. Louis. 
Genetic Nomenclature 
for C. elegans 
http://wiki.wormbase.org/ 
index.php/UserGuide: 
Nomenclature 
A guide to the proper genetic 
nomenclature for C. elegans.  
Supervised by wormbase.org 
and the Caenorhabditis 
Genetics Center at the 
University of Minnesota. 95 
 
Table 3.  Essential amino acids
[27] and neurotransmitters
[59]
 in C. elegans and humans. 
Amino acids  C. elegans  Humans 
Arginine   E
[a]  E in development 
Histidine  E  E 
Lysine  E  E 
Aspartic acid  NE  NE 
Glutamic acid  NE  NE 
Serine  NE  NE 
Threonine  E  E 
Asparagine  NE  NE 
Glutamine  NE  NE 
Alanine  NE  NE 
Isoleucine  E  E 
Leucine  E  E 
Methionine  E  E 
Phenylalanine  E  E 
Tryptophan  E  E 
Tyrosine  NE  E in development 
Valine  E  E 
Cysteine  NE  E in development 
Glycine  NE  NE 
Proline  NE  NE 
Neurotransmitters  Used in C. elegans?  Used in Humans? 
Acetylcholine  Y  Y 
GABA  Y  Y 
Nitric oxide  Y  Y 
Serotonin  Y  Y 
Dopamine  Y  Y 
Glutamic acid  Y  Y 
Octapamine  Y  N 
Tyramine  Y  N 
Epinephrine  N  Y 
Norepinephrine  N  Y 
Histamine  N  Y 
Neuropeptides
[b]  Y  Y 
[a]  E: essential NE: non-essential 
[b]  Although humans and worms use neuropeptides, they do not use the same neuropeptides. 96 
 
Table 4.  Human diseases studied in C. elegans 
Disease  Approach  Phenotype of disease in worm  References 
Alzheimer’s Disease  HTS for inhibitors of presenilin 
homolog in worm 
Decreased egg-laying  [273] 
  Transgenic expression of 
amyloid-β in worm 
Protein oxidation; paralysis; formation of 
amyloid fibrils 
[123, 125, 129, 
274] 
Huntington’s Disease  Transgenic expression of 
polyQ expansions in worm 
Decreased locomotion; increased rate of 
age-related decline in locomotion; formation 
of insoluble polyQ aggregates 
[126, 127] 
  Transgenic expression of 
Huntingtin and mutation of 
C. elegans polyQ enhancer 
gene (pqe-1) 
Neuronal death and degeneration; 
decreased food consumption 
[275, 276] 
Parkinson’s Disease  Transgenic expression of 
human α-synuclein in worm 
Altered dopamine (DA) concentration; 
degeneration of DAergic neurons; reduced 
motility; altered distribution of DA vesicles at 
synapse 
[277, 278] 
Depression  Mutation of genes in 
conserved serotonergic 
signaling pathway to 
determine mechanism of 
antidepressants 
Enhanced serotonergic signaling increased 
egg-laying; reduced serotonergic signaling 
decreased egg-laying 
[121] 
Duchenne muscular 
dystrophy 
Worm has dystrophin-like 
gene (dys-1).  Examined 
effects of dys-1 mutations. 
Decreased locomotion; muscle cell 
degeneration; altered response of muscle 
cells to acetylcholine and 
acetylchoinesterase inhibitors 
[279, 280] 
Lung cancer  Transgenic expression of wild-
type and mutant c-Met in 
worm 
Decreased locomotion; paralysis; growth 
arrest; changes in body morpology 
[281] 
Carcinogenesis  Exposed worms to known 
carcinogens 
Inhibition of apoptosis in development  [140] 
Tumor formation  Mutation of gld-1, a tumor 
suppression gene in worm 
Tumor-like proliferation of germ cells  [131, 282] 
Bacterial infection  Fed worms infectious bacteria  Colonization of gut by bacteria; death  [283] 
Diabetes / insulin 
resistance 
Mutation of conserved 
hexosamine signaling 
pathway 
Elevated storage of glycogen and trehalose; 
decreased storage of lipids 
[33, 119] 
Human mitochondrial-
associated diseases 
Mutation of conserved 
mitochondrial proteins 
Severe loss-of-function and null mutations 
lead to growth arrest, death; mild loss-of-
function mutations can increase lifespan  
[284] 
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Table 5.  Global prevalence of the helminthic infections in humans 
Helminth 
No. People 
Infected
[144] 
(million) 
Ascaris lumbricoides 
soil-transmitted nematode 
807 
Trichuris trichiura 
“whipworm”; soil-transmitted 
nematode 
604 
Necator americanus 
Anclyostoma duodenale 
“hookworm”; soil-transmitted 
nematodes 
576 
Schistosoma haematobium 
Schistosoma mansoni 
Schistosoma japonicum 
flukes 
207 
Wuchereria bancrofti 
Brugia malayi 
lymphatic filariae; infection 
can cause painful swelling 
of legs and genitals 
(elephantiasis) 
120 
Strongyloides stercoralis 
“threadworm”; soil-
transmitted nematode 
30-100 
Clonorchis sinensis 
Opisthorchis viverinni 
Paragonimus spp. 
Fasciolopsis buski 
Fasciola hepatica 
food-borne flukes 
>40 
Onchocerca volvulus 
filarial nematode; carries 
endosymbiotic bacterium 
that causes “River 
Blindness” 
37 
Loa loa 
filarial nematode 
13 
Taenia solium 
pork tapeworm 
0.4 
Dracunculus medinensis 
“Guinea worm”; filarial 
nematode 
0.01 
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Suggestion for the Table of Contents  
 
The worm—Caenorhabditis elegans—is a popular model organism for genetic research.  
Although the worm is a simple organism, it still exhibits many of the complex phenomena found 
in higher organisms, including aging, behavior, cognition, and susceptibility to disease.  This 
review provides an introduction to worm biology and argues that C. elegans is a useful system 
for the examination of complex biological phenomena from a chemical perspective.   
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